AnatomyDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPsychiatry and PsychologyPhenomena and ProcessesDisciplines and OccupationsAnthropology, Education, Sociology and Social PhenomenaTechnology, Industry, AgricultureInformation ScienceNamed GroupsHealth CarePublication CharacteristicsGeographicals
Patents as TopicForamen Ovale, PatentHeart Septal Defects, AtrialIntellectual PropertyEmbolism, ParadoxicalSeptal Occluder DevicePatentsVascular PatencyInventionsEchocardiography, TransesophagealDrug IndustryPeriodicals as TopicCongresses as TopicLicensureCardiac CatheterizationTreatment OutcomeTextbooks as TopicAbstracting and Indexing as TopicLegislation, DrugReview Literature as TopicBiotechnologyProstheses and ImplantsUrachusBalloon OcclusionDuctus ArteriosusRandomized Controlled Trials as TopicBlood Vessel ProsthesisInfant, NewbornAngiographyFollow-Up StudiesGuidelines as TopicEvidence-Based MedicineTerminology as TopicBenchmarkingResearchProgrammed Instruction as TopicTime FactorsGraft Occlusion, VascularInfant, PrematureLigationRosaniline DyesDrugs, GenericAortographyInterviews as TopicCardiac Surgical ProceduresHeart AneurysmForamen OvaleEmbolismBlood Vessel Prosthesis ImplantationIbuprofenHerbals as TopicInfant, Premature, DiseasesPolytetrafluoroethyleneValsalva ManeuverSaphenous VeinUnited StatesEndarteritisAnastomosis, SurgicalResearch Support as TopicEmbolization, TherapeuticFemoral ArteryEchocardiographyPractice Guidelines as TopicBiomedical ResearchRetrospective StudiesFemoral VeinBookplates as TopicBroadsides as TopicIntracranial EmbolismHeart Septal DefectsStentsEchocardiography, Doppler, ColorBiosimilar PharmaceuticalsPatient Education as TopicClinical Trials as TopicPostoperative ComplicationsStrokeProsthesis DesignArterial Occlusive DiseasesVena Cava, InferiorUrachal CystTesticular HydroceleCurriculumPopliteal ArteryEconomic CompetitionArteriovenous Shunt, SurgicalMigraine with AuraVeinsWebcasts as TopicReoperationProspective StudiesMammary ArteriesInvestmentsTomography, X-Ray ComputedManuscripts as TopicMeta-Analysis as TopicEquipment DesignIndomethacinLawyersVascular Surgical ProceduresAneurysmHeart Defects, CongenitalPolyethylene TerephthalatesConstriction, PathologicRisk FactorsHeart SeptumTibial ArteriesDehumanizationEmpirical ResearchThrombosisRecurrenceHeart MurmursPharmaceutical PreparationsRadiography, InterventionalCommerce
Patents as Topic: Exclusive legal rights or privileges applied to inventions, plants, etc.Foramen Ovale, Patent: A condition in which the FORAMEN OVALE in the ATRIAL SEPTUM fails to close shortly after birth. This results in abnormal communications between the two upper chambers of the heart. An isolated patent ovale foramen without other structural heart defects is usually of no hemodynamic significance.Heart Septal Defects, Atrial: Developmental abnormalities in any portion of the ATRIAL SEPTUM resulting in abnormal communications between the two upper chambers of the heart. Classification of atrial septal defects is based on location of the communication and types of incomplete fusion of atrial septa with the ENDOCARDIAL CUSHIONS in the fetal heart. They include ostium primum, ostium secundum, sinus venosus, and coronary sinus defects.Intellectual Property: Property, such as patents, trademarks, and copyright, that results from creative effort. The Patent and Copyright Clause (Art. 1, Sec. 8, cl. 8) of the United States Constitution provides for promoting the progress of science and useful arts by securing for limited times to authors and inventors, the exclusive right to their respective writings and discoveries. (From Black's Law Dictionary, 5th ed, p1014)Embolism, Paradoxical: Blockage of an artery due to passage of a clot (THROMBUS) from a systemic vein to a systemic artery without its passing through the lung which acts as a filter to remove blood clots from entering the arterial circulation. Paradoxical embolism occurs when there is a defect that allows a clot to cross directly from the right to the left side of the heart as in the cases of ATRIAL SEPTAL DEFECTS or open FORAMEN OVALE. Once in the arterial circulation, a clot can travel to the brain, block an artery, and cause a STROKE.Septal Occluder Device: A CATHETER-delivered implant used for closing abnormal holes in the cardiovascular system, especially HEART SEPTAL DEFECTS; or passageways intentionally made during cardiovascular surgical procedures.PatentsVascular Patency: The degree to which BLOOD VESSELS are not blocked or obstructed.Inventions: A novel composition, device, or process, independently conceived de novo or derived from a pre-existing model.Echocardiography, Transesophageal: Ultrasonic recording of the size, motion, and composition of the heart and surrounding tissues using a transducer placed in the esophagus.Drug Industry: That segment of commercial enterprise devoted to the design, development, and manufacture of chemical products for use in the diagnosis and treatment of disease, disability, or other dysfunction, or to improve function.Periodicals as Topic: A publication issued at stated, more or less regular, intervals.Congresses as Topic: Conferences, conventions or formal meetings usually attended by delegates representing a special field of interest.Licensure: The legal authority or formal permission from authorities to carry on certain activities which by law or regulation require such permission. It may be applied to licensure of institutions as well as individuals.Cardiac Catheterization: Procedures in which placement of CARDIAC CATHETERS is performed for therapeutic or diagnostic procedures.Treatment Outcome: Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series.Textbooks as Topic: Books used in the study of a subject that contain a systematic presentation of the principles and vocabulary of a subject.Abstracting and Indexing as Topic: Activities performed to identify concepts and aspects of published information and research reports.Legislation, Drug: Laws concerned with manufacturing, dispensing, and marketing of drugs.Review Literature as Topic: Published materials which provide an examination of recent or current literature. Review articles can cover a wide range of subject matter at various levels of completeness and comprehensiveness based on analyses of literature that may include research findings. The review may reflect the state of the art. It also includes reviews as a literary form.Biotechnology: Body of knowledge related to the use of organisms, cells or cell-derived constituents for the purpose of developing products which are technically, scientifically and clinically useful. Alteration of biologic function at the molecular level (i.e., GENETIC ENGINEERING) is a central focus; laboratory methods used include TRANSFECTION and CLONING technologies, sequence and structure analysis algorithms, computer databases, and gene and protein structure function analysis and prediction.Prostheses and Implants: Artificial substitutes for body parts, and materials inserted into tissue for functional, cosmetic, or therapeutic purposes. Prostheses can be functional, as in the case of artificial arms and legs, or cosmetic, as in the case of an artificial eye. Implants, all surgically inserted or grafted into the body, tend to be used therapeutically. IMPLANTS, EXPERIMENTAL is available for those used experimentally.Urachus: An embryonic structure originating from the ALLANTOIS. It is a canal connecting the fetal URINARY BLADDER and the UMBILICUS. It is normally converted into a fibrous cord postnatally. When the canal fails to be filled and remains open (patent urachus), urine leaks through the umbilicus.Balloon Occlusion: Use of a balloon CATHETER to block the flow of blood through an artery or vein.Ductus Arteriosus: A fetal blood vessel connecting the pulmonary artery with the descending aorta.Randomized Controlled Trials as Topic: Works about clinical trials that involve at least one test treatment and one control treatment, concurrent enrollment and follow-up of the test- and control-treated groups, and in which the treatments to be administered are selected by a random process, such as the use of a random-numbers table.Blood Vessel Prosthesis: Device constructed of either synthetic or biological material that is used for the repair of injured or diseased blood vessels.Infant, Newborn: An infant during the first month after birth.Angiography: Radiography of blood vessels after injection of a contrast medium.Follow-Up Studies: Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease.Guidelines as Topic: A systematic statement of policy rules or principles. Guidelines may be developed by government agencies at any level, institutions, professional societies, governing boards, or by convening expert panels. The text may be cursive or in outline form but is generally a comprehensive guide to problems and approaches in any field of activity. For guidelines in the field of health care and clinical medicine, PRACTICE GUIDELINES AS TOPIC is available.Evidence-Based Medicine: An approach of practicing medicine with the goal to improve and evaluate patient care. It requires the judicious integration of best research evidence with the patient's values to make decisions about medical care. This method is to help physicians make proper diagnosis, devise best testing plan, choose best treatment and methods of disease prevention, as well as develop guidelines for large groups of patients with the same disease. (from JAMA 296 (9), 2006)Terminology as Topic: The terms, expressions, designations, or symbols used in a particular science, discipline, or specialized subject area.Benchmarking: Method of measuring performance against established standards of best practice.Research: Critical and exhaustive investigation or experimentation, having for its aim the discovery of new facts and their correct interpretation, the revision of accepted conclusions, theories, or laws in the light of newly discovered facts, or the practical application of such new or revised conclusions, theories, or laws. (Webster, 3d ed)Programmed Instruction as Topic: Instruction in which learners progress at their own rate using workbooks, textbooks, or electromechanical devices that provide information in discrete steps, test learning at each step, and provide immediate feedback about achievement. (ERIC, Thesaurus of ERIC Descriptors, 1996).Time Factors: Elements of limited time intervals, contributing to particular results or situations.Graft Occlusion, Vascular: Obstruction of flow in biological or prosthetic vascular grafts.Infant, Premature: A human infant born before 37 weeks of GESTATION.Ligation: Application of a ligature to tie a vessel or strangulate a part.Rosaniline Dyes: Compounds that contain the triphenylmethane aniline structure found in rosaniline. Many of them have a characteristic magenta color and are used as COLORING AGENTS.Drugs, Generic: Drugs whose drug name is not protected by a trademark. They may be manufactured by several companies.Aortography: Radiographic visualization of the aorta and its branches by injection of contrast media, using percutaneous puncture or catheterization procedures.Interviews as Topic: Conversations with an individual or individuals held in order to obtain information about their background and other personal biographical data, their attitudes and opinions, etc. It includes school admission or job interviews.Cardiac Surgical Procedures: Surgery performed on the heart.Heart Aneurysm: A localized bulging or dilatation in the muscle wall of a heart (MYOCARDIUM), usually in the LEFT VENTRICLE. Blood-filled aneurysms are dangerous because they may burst. Fibrous aneurysms interfere with the heart function through the loss of contractility. True aneurysm is bound by the vessel wall or cardiac wall. False aneurysms are HEMATOMA caused by myocardial rupture.Foramen Ovale: An opening in the wall between the right and the left upper chambers (HEART ATRIA) of a fetal heart. Oval foramen normally closes soon after birth; when it fails to close the condition is called PATENT OVAL FORAMEN.Embolism: Blocking of a blood vessel by an embolus which can be a blood clot or other undissolved material in the blood stream.Blood Vessel Prosthesis Implantation: Surgical insertion of BLOOD VESSEL PROSTHESES to repair injured or diseased blood vessels.Ibuprofen: A nonsteroidal anti-inflammatory agent with analgesic properties used in the therapy of rheumatism and arthritis.Herbals as Topic: Works about books, articles or other publications on herbs or plants describing their medicinal value.Infant, Premature, DiseasesPolytetrafluoroethylene: Homopolymer of tetrafluoroethylene. Nonflammable, tough, inert plastic tubing or sheeting; used to line vessels, insulate, protect or lubricate apparatus; also as filter, coating for surgical implants or as prosthetic material. Synonyms: Fluoroflex; Fluoroplast; Ftoroplast; Halon; Polyfene; PTFE; Tetron.Valsalva Maneuver: Forced expiratory effort against a closed GLOTTIS.Saphenous Vein: The vein which drains the foot and leg.United StatesEndarteritis: Inflammation of the inner endothelial lining (TUNICA INTIMA) of an artery.Anastomosis, Surgical: Surgical union or shunt between ducts, tubes or vessels. It may be end-to-end, end-to-side, side-to-end, or side-to-side.Research Support as Topic: Financial support of research activities.Embolization, Therapeutic: A method of hemostasis utilizing various agents such as Gelfoam, silastic, metal, glass, or plastic pellets, autologous clot, fat, and muscle as emboli. It has been used in the treatment of spinal cord and INTRACRANIAL ARTERIOVENOUS MALFORMATIONS, renal arteriovenous fistulas, gastrointestinal bleeding, epistaxis, hypersplenism, certain highly vascular tumors, traumatic rupture of blood vessels, and control of operative hemorrhage.Femoral Artery: The main artery of the thigh, a continuation of the external iliac artery.Echocardiography: Ultrasonic recording of the size, motion, and composition of the heart and surrounding tissues. The standard approach is transthoracic.Practice Guidelines as Topic: Directions or principles presenting current or future rules of policy for assisting health care practitioners in patient care decisions regarding diagnosis, therapy, or related clinical circumstances. The guidelines may be developed by government agencies at any level, institutions, professional societies, governing boards, or by the convening of expert panels. The guidelines form a basis for the evaluation of all aspects of health care and delivery.Biomedical Research: Research that involves the application of the natural sciences, especially biology and physiology, to medicine.Retrospective Studies: Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons.Femoral Vein: The vein accompanying the femoral artery in the same sheath; it is a continuation of the popliteal vein and becomes the external iliac vein.Bookplates as Topic: Labels pasted in books to mark their ownership and sometimes to indicate their location in a library. Private bookplates are often ornate or artistic: simpler and smaller ones bearing merely the owner's name are called "book labels." They are usually pasted on the front endpaper of books. (From Harrod, The Librarians' Glossary and Reference Book, 4th rev ed & Random House Unabridged Dictionary, 2d ed)Broadsides as Topic: Published pieces of paper or other material, usually printed on one side and intended to be read unfolded and usually intended to be posted, publicly distributed, or sold. (From Genre Terms: A Thesaurus for Use in Rare Book and Special Collections Cataloguing, 2d ed)Intracranial Embolism: Blocking of a blood vessel in the SKULL by an EMBOLUS which can be a blood clot (THROMBUS) or other undissolved material in the blood stream. Most emboli are of cardiac origin and are associated with HEART DISEASES. Other non-cardiac sources of emboli are usually associated with VASCULAR DISEASES.Heart Septal Defects: Abnormalities in any part of the HEART SEPTUM resulting in abnormal communication between the left and the right chambers of the heart. The abnormal blood flow inside the heart may be caused by defects in the ATRIAL SEPTUM, the VENTRICULAR SEPTUM, or both.Stents: Devices that provide support for tubular structures that are being anastomosed or for body cavities during skin grafting.Echocardiography, Doppler, Color: Echocardiography applying the Doppler effect, with the superposition of flow information as colors on a gray scale in a real-time image.Biosimilar Pharmaceuticals: BIOLOGIC PRODUCTS that are imitations but not exact replicas of innovator products.Patient Education as Topic: The teaching or training of patients concerning their own health needs.Clinical Trials as Topic: Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries.Postoperative Complications: Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery.Stroke: A group of pathological conditions characterized by sudden, non-convulsive loss of neurological function due to BRAIN ISCHEMIA or INTRACRANIAL HEMORRHAGES. Stroke is classified by the type of tissue NECROSIS, such as the anatomic location, vasculature involved, etiology, age of the affected individual, and hemorrhagic vs. non-hemorrhagic nature. (From Adams et al., Principles of Neurology, 6th ed, pp777-810)Prosthesis Design: The plan and delineation of prostheses in general or a specific prosthesis.Arterial Occlusive Diseases: Pathological processes which result in the partial or complete obstruction of ARTERIES. They are characterized by greatly reduced or absence of blood flow through these vessels. They are also known as arterial insufficiency.Vena Cava, Inferior: The venous trunk which receives blood from the lower extremities and from the pelvic and abdominal organs.Urachal Cyst: Cyst occurring in a persistent portion of the urachus, presenting as an extraperitoneal mass in the umbilical region. It is characterized by abdominal pain, and fever if infected. It may rupture, leading to peritonitis, or it may drain through the umbilicus.Testicular Hydrocele: Accumulation of serous fluid between the layers of membrane (tunica vaginalis) covering the TESTIS in the SCROTUM.Curriculum: A course of study offered by an educational institution.Popliteal Artery: The continuation of the femoral artery coursing through the popliteal fossa; it divides into the anterior and posterior tibial arteries.Economic Competition: The effort of two or more parties to secure the business of a third party by offering, usually under fair or equitable rules of business practice, the most favorable terms.Arteriovenous Shunt, Surgical: Surgical shunt allowing direct passage of blood from an artery to a vein. (From Dorland, 28th ed)Migraine with Aura: A subtype of migraine disorder, characterized by recurrent attacks of reversible neurological symptoms (aura) that precede or accompany the headache. Aura may include a combination of sensory disturbances, such as blurred VISION; HALLUCINATIONS; VERTIGO; NUMBNESS; and difficulty in concentrating and speaking. Aura is usually followed by features of the COMMON MIGRAINE, such as PHOTOPHOBIA; PHONOPHOBIA; and NAUSEA. (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)Veins: The vessels carrying blood away from the capillary beds.Webcasts as Topic: Transmission of live or pre-recorded audio or video content via connection or download from the INTERNET.Reoperation: A repeat operation for the same condition in the same patient due to disease progression or recurrence, or as followup to failed previous surgery.Prospective Studies: Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group.Mammary Arteries: Arteries originating from the subclavian or axillary arteries and distributing to the anterior thoracic wall, mediastinal structures, diaphragm, pectoral muscles and mammary gland.Investments: Use for articles on the investing of funds for income or profit.Tomography, X-Ray Computed: Tomography using x-ray transmission and a computer algorithm to reconstruct the image.Manuscripts as Topic: Compositions written by hand, as one written before the invention or adoption of printing. A manuscript may also refer to a handwritten copy of an ancient author. A manuscript may be handwritten or typewritten as distinguished from a printed copy, especially the copy of a writer's work from which printed copies are made. (Webster, 3d ed)Meta-Analysis as Topic: A quantitative method of combining the results of independent studies (usually drawn from the published literature) and synthesizing summaries and conclusions which may be used to evaluate therapeutic effectiveness, plan new studies, etc., with application chiefly in the areas of research and medicine.Equipment Design: Methods of creating machines and devices.Indomethacin: A non-steroidal anti-inflammatory agent (NSAID) that inhibits the enzyme cyclooxygenase necessary for the formation of prostaglandins and other autacoids. It also inhibits the motility of polymorphonuclear leukocytes.Lawyers: Persons whose profession is to give legal advice and assistance to clients and represent them in legal matters. (American Heritage Dictionary, 3d ed)Vascular Surgical Procedures: Operative procedures for the treatment of vascular disorders.Aneurysm: Pathological outpouching or sac-like dilatation in the wall of any blood vessel (ARTERIES or VEINS) or the heart (HEART ANEURYSM). It indicates a thin and weakened area in the wall which may later rupture. Aneurysms are classified by location, etiology, or other characteristics.Heart Defects, Congenital: Developmental abnormalities involving structures of the heart. These defects are present at birth but may be discovered later in life.Polyethylene Terephthalates: Polyester polymers formed from terephthalic acid or its esters and ethylene glycol. They can be formed into tapes, films or pulled into fibers that are pressed into meshes or woven into fabrics.Constriction, Pathologic: The condition of an anatomical structure's being constricted beyond normal dimensions.Risk Factors: An aspect of personal behavior or lifestyle, environmental exposure, or inborn or inherited characteristic, which, on the basis of epidemiologic evidence, is known to be associated with a health-related condition considered important to prevent.Heart Septum: This structure includes the thin muscular atrial septum between the two HEART ATRIA, and the thick muscular ventricular septum between the two HEART VENTRICLES.Tibial Arteries: The anterior and posterior arteries created at the bifurcation of the popliteal artery. The anterior tibial artery begins at the lower border of the popliteus muscle and lies along the tibia at the distal part of the leg to surface superficially anterior to the ankle joint. Its branches are distributed throughout the leg, ankle, and foot. The posterior tibial artery begins at the lower border of the popliteus muscle, lies behind the tibia in the lower part of its course, and is found situated between the medial malleolus and the medial process of the calcaneal tuberosity. Its branches are distributed throughout the leg and foot.Dehumanization: The process by which a person or group of persons comes to be regarded or treated as lacking in human qualities.Empirical Research: The study, based on direct observation, use of statistical records, interviews, or experimental methods, of actual practices or the actual impact of practices or policies.Thrombosis: Formation and development of a thrombus or blood clot in the blood vessel.Recurrence: The return of a sign, symptom, or disease after a remission.Heart Murmurs: Heart sounds caused by vibrations resulting from the flow of blood through the heart. Heart murmurs can be examined by HEART AUSCULTATION, and analyzed by their intensity (6 grades), duration, timing (systolic, diastolic, or continuous), location, transmission, and quality (musical, vibratory, blowing, etc).Pharmaceutical Preparations: Drugs intended for human or veterinary use, presented in their finished dosage form. Included here are materials used in the preparation and/or formulation of the finished dosage form.Radiography, Interventional: Diagnostic and therapeutic procedures that are invasive or surgical in nature, and require the expertise of a specially trained radiologist. In general, they are more invasive than diagnostic imaging but less invasive than major surgery. They often involve catheterization, fluoroscopy, or computed tomography. Some examples include percutaneous transhepatic cholangiography, percutaneous transthoracic biopsy, balloon angioplasty, and arterial embolization.Commerce: The interchange of goods or commodities, especially on a large scale, between different countries or between populations within the same country. It includes trade (the buying, selling, or exchanging of commodities, whether wholesale or retail) and business (the purchase and sale of goods to make a profit). (From Random House Unabridged Dictionary, 2d ed, p411, p2005 & p283)

Disease gene patents: overcoming unethical constraints on clinical laboratory medicine. (1/276)

The rapidly growing number of disease gene patents--patents that claim all methods for diagnosis of a particular genetic condition--threatens the ability of physicians to provide medical care to their patients. In the past, patented diagnostic tests were made broadly available to the medical community in the form of test kits or licenses to use the patented test. Disease gene tests, however, are being monopolized by a small number of providers. Monopolization of medical testing services: (a) threatens to restrict research activities; (b) creates unacceptable conflicts of interest; (c) may reduce patient access to testing; (d) may lead to inequitable extensions of patent terms on tests and related discoveries; and (e) grants to patent holders the ability to dictate the standard of care for testing, and to otherwise interfere with the practice of medicine. Because of the risks raised by monopolization, amendment of the patent law to require compulsory licensing of physicians providing medical services is recommended.  (+info)

Essential drugs in the new international economic environment. (2/276)

Recent global developments in the regulation of trade and intellectual property rights threaten to hinder the access of populations in developing countries to essential drugs. The authors argue for state intervention in the health and pharmaceutical markets in order to guarantee equitable access to these products.  (+info)

The future of molecular genetic testing. (3/276)

The potential applications for genetic testing are immense, with most diseases having some aspect influenced by, if not directly caused by, changes in the genome of the patient. The translation of genetic information into medical applications will be influenced by our understanding of the human genome, technological advances, and social, ethical, and legal issues surrounding genetic testing. With time, new genetic information will be translated into clinical tests for the diagnosis of current illness and prediction of future disease risk, and will be used for the development of genetically directed therapies and preventive interventions. Most genetic testing will be highly automated, with only rare genetic disease tests performed manually. The challenge for the clinical genetic laboratory is to keep pace with this information explosion to provide state-of-the-art genetic testing and to ensure that the genetic test results are used in a morally, ethically, and socially responsible way.  (+info)

Pharmaceutical policies in Canada: another example of federal-provincial discord. (4/276)

Pharmaceutical policy in Canada is set at both the federal and provincial levels of government. The federal government is responsible for intellectual property rights of manufacturers (patents) and the initial approval and labelling of prescription drugs and for ensuring overall market competitiveness. The provincial government has responsibility and jurisdiction over the funding of all health care services, including pharmaceuticals. Various interactions between the pharmaceutical industry, the federal and provincial governments and consumers have shaped the current landscape for prescription drugs in Canada. One key failing of the system is that the federal government is almost completely insulated from the impact of its policies because, although it regulates drug prices, it does not buy any drugs. In contrast, provincial governments have no jurisdiction over market competitiveness or pricing, yet end up paying for most of the drug expenditures incurred.  (+info)

Effect of multiple-source entry on price competition after patent expiration in the pharmaceutical industry. (5/276)

OBJECTIVE: To analyze the effect of multiple-source drug entry on price competition after patent expiration in the pharmaceutical industry. DATA SOURCES: Originators and their multiple-source drugs selected from the 35 chemical entities whose patents expired from 1984 through 1987. Data were obtained from various primary and secondary sources for the patents' expiration dates, sales volume and units sold, and characteristics of drugs in the sample markets. STUDY DESIGN: The study was designed to determine significant factors using the study model developed under the assumption that the off-patented market is an imperfectly segmented market. PRINCIPAL FINDINGS: After patent expiration, the originators' prices continued to increase, while the price of multiple-source drugs decreased significantly over time. By the fourth year after patent expiration, originators' sales had decreased 12 percent in dollars and 30 percent in quantity. Multiple-source drugs increased their sales twofold in dollars and threefold in quantity, and possessed about one-fourth (in dollars) and half (in quantity) of the total market three years after entry. CONCLUSION: After patent expiration, multiple-source drugs compete largely with other multiple-source drugs in the price-sensitive sector, but indirectly with the originator in the price-insensitive sector. Originators have first-mover advantages, and therefore have a market that is less price sensitive after multiple-source drugs enter. On the other hand, multiple-source drugs target the price-sensitive sector, using their lower-priced drugs. This trend may indicate that the off-patented market is imperfectly segmented between the price-sensitive and insensitive sector. Consumers as a whole can gain from the entry of multiple-source drugs because the average price of the market continually declines after patent expiration.  (+info)

Pending resolution: the question of who owns DNA. (6/276)

With the emergence of the Human Genome Project and its private counterparts, the U.S. Patent and Trademark Office has begun receiving applications for the patenting of genes and genetic sequences. Earlier patent decisions regarding similar scientific advances limited patents to organisms "made by the hand of man," which would seem to remove discovered genes from patent protection. But many applicants have been successful in attaining patents for genes based on their ability to demonstrate the ultimate utility of the gene, for instance in medicine. One controversy regarding genomic patenting, however, is that patents apparently have been granted for mere gene fragments devoid of much demonstrable utility. Furthermore, critics fear that gene patenting will retard research by squelching scientists' ability to share findings freely.  (+info)

Patenting human genetic material: refocusing the debate. (7/276)

The biotechnology industry has become firmly established over the past twenty years and gene patents have played an important part in this phenomenon. However, concerns have been raised over the patentability of human genetic material, through public protests and international statements, but to little effect. Here we discuss some of these concerns, the patent authorities' response to them, and ways in which to address these issues and to move the debate forward using current legal structures.  (+info)

Patent protection of pharmaceuticals. (8/276)

Patenting of biologically active compounds by academic institutions is discussed, with emphasis on patents for already known compounds.  (+info)

MEDICAL SLINGS - Patent applicationMEDICAL SLINGS - Patent application
0055] The various illustrative slings described herein may be employed with any suitable sling delivery system. By way of example, the slings of the invention may be employed with any delivery systems appropriate for treating urinary incontinence. Such delivery systems include, for example, those delivery systems configured for supra-pubic, pre-pubic, transvaginal or transobturator approaches. Without limitation, exemplary delivery systems, methodologies, sling, sling attachments that may be employed can be found in U.S. patent application Ser. No. 10/460,112, U.S. patent application Ser. No. 10/093,498, U.S. patent application Ser. No. 09/916,983, U.S. patent application Ser. No. 10/093,398, U.S. patent application Ser. No. 10/093,450, U.S. patent application Ser. No. 10/094,371, U.S. patent application Ser. No. 10/092,872, U.S. patent application Ser. No. 09/916,983, U.S. provisional patent application Ser. No. 60/465,722, U.S. patent application Ser. No. 10/094,352, U.S. patent application ...
Patent and Trademark Office Consolidated Notices December 27, 2011 1373Patent and Trademark Office Consolidated Notices December 27, 2011 1373
Korean Intellectual Property Office 209 854 Extension of the Patent Prosecution Highway Pilot Program between the USPTO and the CIPO 210 855 Revised Requirements for Requesting Participation in the Patent Prosecution Highway Pilot Program in the USPTO (between the USPTO and the EPO) 211 858 Patent Prosecution Highway Pilot Program between the United States Patent and Trademark Office and the Danish Patent and Trademark Office 212 864 Extension Of the Patent Prosecution Highway Pilot Program Between the USPTO and the UKIPO 213 865 Patent Prosecution Highway Pilot Program between the United States Patent and Trademark Office and European Patent Office 214 869 Patent Prosecution Highway Pilot Program between the United States Patent and Trademark Office and IP Australia 215 874 Patent Prosecution Highway Pilot Program between the United States Patent and Trademark Office and the Korean Intellectual Property Office 216 879 Patent Prosecution Highway Pilot Program between the United States Patent and ...
Patent and Trademark Office Consolidated Notices December 30, 2008 1337Patent and Trademark Office Consolidated Notices December 30, 2008 1337
Filed in Thailand 145 748 Notice of Right to Claim Priority Based Upon Applications Previously Filed In India 146 749 Right of Priority in Patent and Trademark Applications Available in Taiwan 147 750 Patent Prosecution Highway Pilot Program between the United States Patent and Trademark Office and European Patent Office 148 754 Patent Prosecution Highway Pilot Program between the United States Patent and Trademark Office and IP Australia 149 759 Patent Prosecution Highway Pilot Program between the United States Patent and Trademark Office and the Korean Intellectual Property Office 150 764 Patent Prosecution Highway Pilot Program between the United States Patent and Trademark Office and the Canadian Intellectual Property Office 151 768 Revised Requirements for Requesting Participation in the Patent Prosecution Highway Pilot Program in the USPTO (between the USPTO and the UK IPO) 152 770 Patent Prosecution Highway Pilot Program Between the United States Patent and Trademark Office and the United ...
SYSTEM FOR MEDICAL DATA COLLECTION AND TRANSMISSION - Patent applicationSYSTEM FOR MEDICAL DATA COLLECTION AND TRANSMISSION - Patent application
0001] This application claims priority to U.S. Provisional Patent Application Ser. No. 60/862,743, filed Oct. 24, 2006; and claims priority to and is a continuation of: U.S. Patent Publication No. 20080097908 filed as U.S. Utility patent application Ser. No. 11/876,689 on Oct. 22, 2007; U.S. Patent Publication No. 20080097909 filed as U.S. Utility patent application Ser. No. 11/876,695 on Oct. 22, 2007; U.S. Patent Publication No. 20080097551 filed as U.S. Utility patent application Ser. No. 11/876,708 on Oct. 22, 2007; U.S. Patent Publication No. 20080103554 filed as U.S. Utility patent application Ser. No. 11/876,711 on Oct. 22, 2007; U.S. Patent Publication No. 20080103370 filed as U.S. Utility patent application Ser. No. 11/876,713 on Oct. 22, 2007; U.S. Patent Publication No. 20080097910 filed as U.S. Utility patent application Ser. No. 11/876,719 on Oct. 22, 2007; U.S. Patent Publication No. 20080215360 filed as U.S. Utility patent application Ser. No. 11/876,725 on Oct. 22, 2007; U.S. ...
Patent application trends of induced pluripotent stem cell technologies in the United States, Japanese, and European...Patent application trends of induced pluripotent stem cell technologies in the United States, Japanese, and European...
TY - JOUR. T1 - Patent application trends of induced pluripotent stem cell technologies in the United States, Japanese, and European applications. AU - Morita, Yasushi. AU - Okura, Hanayuki. AU - Matsuyama, Akifumi. PY - 2019/1/1. Y1 - 2019/1/1. N2 - Patent application trends were investigated for induced pluripotent stem cell (iPSC) technologies, particularly disease-specific cell technologies related to iPSCs, in the U.S., Japanese, and European applications during 2017. The number of patent applications for iPSC technologies was 1516 in the United States, 895 in Japan, and 420 in Europe, with 5% of applications for disease-specific cell technologies. In contrast, the percentages of patent applications for iPSC preparation and differentiation technologies were 17% and 23%, respectively. Patent applications for disease-specific cell technologies were classified into four technical fields and 14 disorder groups. In the technical fields, patent applications for genetically engineered cell ...
Trademarks | WebGURUTrademarks | WebGURU
Trademark is a distinctive logo, phrase, or design such as "Dunkin Donuts®" or "Microsoft®" that uniquely identifies a particular commercial product or series of products with a specific commercial supplier. The symbols ™ or ® are often used to alert the public to the trademark. Anyone claiming ownership of a trademark can use ™ to alert others to their ownership of a trademark. The ® symbol on the other hand indicates that the trademark has been officially registered with the United States Patent and Trademark Office. Federal registration of a trademark is useful in preventing foreign infringement on the trademark and in obtaining registration rights to the trademark outside the United States.. ...
Products Portfolio | Products | Takeda Pharmaceuticals U.S.A., IncProducts Portfolio | Products | Takeda Pharmaceuticals U.S.A., Inc
OSENI is a trademark of Takeda Pharmaceutical Company Limited registered with the U.S. Patent and Trademark Office and used under license by Takeda Pharmaceuticals America, Inc.. PREVACID is a trademark registered in the U.S. Patent and Trademark Office and SoluTab is a trademark of Takeda Pharmaceuticals U. S. A., Inc. and used under license by Takeda Pharmaceuticals America, Inc.. PREVPAC and PREVACID are trademarks of Takeda Pharmaceuticals U. S. A., Inc. registered in the U.S. Patent and Trademark Office and used under license by Takeda Pharmaceuticals America, Inc.. Rozerem is a trademark of Takeda Pharmaceutical Company Limited registered with the U.S. Patent and Trademark Office and used under license by Takeda Pharmaceuticals America, Inc.. TRINTELLIX is a trademark of H. Lundbeck A/S and used under license by Takeda Pharmaceuticals America, Inc.. ULORIC is a trademark of Teijin Limited registered with the U.S. Patent and Trademark Office and used under license by Takeda Pharmaceuticals ...
Trademarks - Citrix ChinaTrademarks - Citrix China
Last updated: September 15, 2020. The following trademarks and service marks are the property of Citrix Systems, Inc., and may be registered with the United States Patent and Trademark Office and in other countries. Citrix may own additional trademarks or service marks that do not appear on the list below, and such omission does not constitute a waiver of any rights Citrix has established in any such mark.. Before you refer to any Citrix trademark, review the Citrix Trademark & Copyright Guidelines, which set forth the basic rules for using Citrix trademarks. If you have questions regarding the Guidelines, or would like to request permission to use a Citrix trademark in a manner not permitted by the Guidelines, please contact [email protected] ...
Trademark Trial and Appeal Board « Ryder Lu Trademark BlogTrademark Trial and Appeal Board « Ryder Lu Trademark Blog
To the great joy of some and the great outrage of others, the United States Patent and Trademark Office Trademark Trial and Appeal Board cancelled six federal trademark registrations for the name of the Washington Redskins on July 18, 2014. The cancellations came as a result of a long battle by Native American individuals and groups, since at least the early 1990s, to petition the U.S. Patent and Trademark Office to agree that the name was offensive to Native Americans and thus undeserving of trademark protection under federal law 15 U.S.C. §1052. The portion of the Lanham Act in Section 1052 disallows trademark registration for any mark that "[c]onsists of or comprises immoral, deceptive, or scandalous matter; or matter which may disparage or falsely suggest a connection with persons, living or dead, institutions, beliefs, or national symbols, or bring them into contempt, or disrepute.". The direct impetus of the recent cancellations was a petition filed by six Native American individuals in ...
Patent Applications For Image Analysis, Enhancement, and Processing (City): SAGE StatsPatent Applications For Image Analysis, Enhancement, and Processing (City): SAGE Stats
Data are calculated estimates based on identified and available U.S. geographies. Not all U.S. geographies and/or patents are included due to spelling variations and errors of geography names committed by patent applicants. Estimates do not include international filings. Use extreme caution when comparing across time and geographies.. Years Available: 2007-2014. Permanent Link: http://data.sagepub.com/sagestats/13781. General Notes: Classification code 382. For more details, please visit http://www.uspto.gov/web/patents/classification/uspc382/defs382.htm. Patents and patent applications are filed by the United States Patent Classification (USPC) code system developed by the U.S. Patent and Trademark Office (USPTO) in the Department of Commerce. Total counts are aggregated by geography and classification for which there is available data. Classifications available on SAGE Business Stats represent the top 10% classifications the USPTO uses to categorize patents and patent applications. In some ...
Bangladesh: Trademarks Act, 2009 (Act No. XIX of 2009)Bangladesh: Trademarks Act, 2009 (Act No. XIX of 2009)
49. Use of one of associated or substantially identical trademarks equivalent to use of another.⎯(1) Where under the provisions of this Act. the use a registered trademark is required to be proved for any purpose, the Tribunal may, if and so far as it shall think right, accept the use of a registered associated trademark, or the trademark with additions or alterations not substantially affecting its identity, as an equivalent for the use required to be proved. (2) The use of the whole of a registered trademark shall for the purposes of this Act be deemed to be also a use of any trademark being a part thereof and registered in accordance with sub-section (1) of section 12 of this Act in the name of the same proprietor. 50. Use of trademark for export trade and use when form of trade connection changes :⎯(1) The application in Bangladesh of a trademark to goods or services to be exported from Bangladesh and any other law done in Bangladesh in relation to goods or services, to be so exported ...
Discrimination against foreigners in the patent system : evidence from standard-essential patents</em>...Discrimination against foreigners in the patent system : evidence from standard-essential patents</em>...
TY - CONF. T1 - Discrimination against foreigners in the patent system : evidence from standard-essential patents. AU - de Rassenfosse, G.. AU - Raiteri, Emilio. AU - Bekkers, R.N.A.. PY - 2017/6. Y1 - 2017/6. N2 - This paper tests for traces of discrimination against foreign firms in the patent prosecution process. It focuses on the case of China and looks specifically at patent applications declared as essential to a technological standard. The choice of standard-essential patents (SEPs) is particularly suited because of the strategic importance of such patents for Chinas indigenous innovation program. We exploit information on the timing of disclosure as SEP (before or after the patent application enters examination) to infer the likely presence of discrimination. We find that patent applications by foreign firms are treated unfavorably when examiners know that they are declared as standard essential. We interpret this result as a case of technology protectionism.. AB - This paper tests ...
Patent - WikipediaPatent - Wikipedia
The grant and enforcement of patents are governed by national laws, and also by international treaties, where those treaties have been given effect in national laws. Patents are granted by national or regional patent offices.[29] A given patent is therefore only useful for protecting an invention in the country in which that patent is granted. In other words, patent law is territorial in nature. When a patent application is published, the invention disclosed in the application becomes prior art and enters the public domain (if not protected by other patents) in countries where a patent applicant does not seek protection, the application thus generally becoming prior art against anyone (including the applicant) who might seek patent protection for the invention in those countries. Commonly, a nation or a group of nations forms a patent office with responsibility for operating that nations patent system, within the relevant patent laws. The patent office generally has responsibility for the grant ...
Japan Patent Office - WikipediaJapan Patent Office - Wikipedia
Coordinates: 35°40′15.56″N 139°44′45.15″E / 35.6709889°N 139.7458750°E / 35.6709889; 139.7458750 The Japan Patent Office (特許庁, Tokkyochō, JPO) is a Japanese governmental agency in charge of industrial property right affairs, under the Ministry of Economy, Trade and Industry. The Japan Patent Office is located in Kasumigaseki, Chiyoda, Tokyo and is one of the worlds largest patent offices. The Japan Patent Offices mission is to promote the growth of the Japanese economy and industry by administering the laws relating to patents, utility models, designs, and trademarks. (Copyright affairs are administered by the Agency for Cultural Affairs.) The Japan Patent Office is headed by a commissioner and consists of seven departments: General Affairs Department Trademark, Design, and Administrative Affairs Department, in charge of examining trademark right applications, design right applications and formalities check of all applications including patent applications First ...
Justices say law on offensive trademarks is unconstitutional - Boston News, Weather, Sports | WHDH 7NewsJustices say law on offensive trademarks is unconstitutional - Boston News, Weather, Sports | WHDH 7News
WASHINGTON (AP) - The Supreme Court on Monday struck down part of a law that bans offensive trademarks, ruling in favor of an Asian-American rock band called the Slants and giving a major boost to the Washington Redskins in their separate legal fight over the team name.. The justices were unanimous in saying that the 71-year-old trademark law barring disparaging terms infringes free speech rights guaranteed in the Constitutions First Amendment.. "It offends a bedrock First Amendment principle: Speech may not be banned on the ground that it expresses ideas that offend," Justice Samuel Alito said in his opinion for the court.. Slants founder Simon Tam tried to trademark the band name in 2011, but the U.S. Patent and Trademark Office denied the request on the ground that it disparages Asians. A federal appeals court in Washington later said the law barring offensive trademarks is unconstitutional and the Supreme Court agreed.. The Redskins made similar arguments after the trademark office ruled in ...
Colombia: gateway to South Americas Patent Prosecution Highway | Insights | DLA Piper Global Law FirmColombia: gateway to South America's Patent Prosecution Highway | Insights | DLA Piper Global Law Firm
Colombia has reached an agreement with the USPTO to participate in the Patent Prosecution Highway, becoming the first South American country to gain such status. With Colombias sturdy economy and confident move into the global marketplace, this agreement could not come at a better time. Understanding the need for more robust patent laws, the Colombian government is aggressively reshaping its IP system. The authors had the opportunity to meet with Jose Luis Londoño Fernández, Superintendent of Industrial Property (Colombias equivalent to the USPTO). He was enthusiastic about the Colombian patent system and the Patent Prosecution Highway and is eagerly seeking to educate Colombians and the global public about the mechanisms available for protecting their ideas and innovations. Mr. Londoño believes so strongly in patent protection that he is in the process of separating the patent office from the trademark and copyright office to allow the patent department to rapidly expand. Mr. Londoños ...
DECLARATION of Emanuel Petricoin, Ph for Association For Molecular Pathology et al v. United States Patent and Trademark Office...DECLARATION of Emanuel Petricoin, Ph for Association For Molecular Pathology et al v. United States Patent and Trademark Office...
Association For Molecular Pathology et al v. United States Patent and Trademark Office et al Doc. 203 UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK ---------------------------------------------------------------------x ASSOCIATION FOR MOLECULAR PATHOLOGY; AMERICAN COLLEGE OF MEDICAL GENETICS; AMERICAN SOCIETY FOR CLINICAL PATHOLOGY; COLLEGE OF AMERICAN PATHOLOGISTS; HAIG KAZAZIAN, MD; ARUPA GANGULY, PhD; WENDY CHUNG, MD, PhD; HARRY OSTRER, MD; DAVID LEDBETTER, PhD; STEPHEN WARREN, PhD; ELLEN MATLOFF, M.S., ELSA REICH, M.S.; BREAST CANCER ACTION; BOSTON WOMENS HEALTH BOOK COLLECTIVE; LISBETH CERIANI; RUNI LIMARY; GENAE GIRARD; PATRICE FORTUNE; VICKY THOMASON; KATHLEEN RAKER, Plaintiffs, v. UNITED STATES PATENT AND TRADEMARK OFFICE; MYRIAD GENETICS; LORRIS BETZ, ROGER BOYER, JACK BRITTAIN, ARNOLD B. COMBE, RAYMOND GESTELAND, JAMES U. JENSEN, JOHN KENDALL MORRIS, THOMAS PARKS, DAVID W. PERSHING, and MICHAEL K. YOUNG, in their official capacity as Directors of the University of Utah ...
RULE 56 for Association For Molecular Pathology et al v. United States Patent and Trademark Office et al :: Justia Dockets &...RULE 56 for Association For Molecular Pathology et al v. United States Patent and Trademark Office et al :: Justia Dockets &...
Association For Molecular Pathology et al v. United States Patent and Trademark Office et al Doc. 63 UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK --------------------------------------------------------------------------x ASSOCIATION FOR MOLECULAR PATHOLOGY; AMERICAN COLLEGE OF MEDICAL GENETICS; AMERICAN SOCIETY FOR CLINICAL PATHOLOGY; COLLEGE OF AMERICAN PATHOLOGISTS; HAIG KAZAZIAN, MD; ARUPA GANGULY, PhD; WENDY CHUNG, MD, PhD; HARRY OSTRER, MD; DAVID LEDBETTER, PhD; STEPHEN WARREN, PhD; ELLEN MATLOFF, M.S.; ELSA REICH, M.S.; BREAST CANCER ACTION; BOSTON WOMENS HEALTH BOOK COLLECTIVE; LISBETH CERIANI; RUNI LIMARY; GENAE GIRARD; PATRICE FORTUNE; VICKY THOMASON; KATHLEEN RAKER, Plaintiffs, 09 Civ. 4515 (RWS) ECF Case v. UNITED STATES PATENT AND TRADEMARK OFFICE; MYRIAD GENETICS; LORRIS BETZ, ROGER BOYER, JACK BRITTAIN, ARNOLD B. COMBE, RAYMOND GESTELAND, JAMES U. JENSEN, JOHN KENDALL MORRIS, THOMAS PARKS, DAVID W. PERSHING, and MICHAEL K. YOUNG, in their official capacity as ...
Half-Life 3 trademark registered by Valve. Is this it!? - GameZoneHalf-Life 3 trademark registered by Valve. Is this it!? - GameZone
Could it be happening!? All it took was a government shutdown to convince Valve to take what looks to be the next step towards Half-Life 3. As spotted by NeoGAF, Valve has registered Half-Life 3 with Europes trademarks office, the OHIM.. Upon visiting the actual European trademark office website and looking up the trademark (#012180394), you can clearly see its legit. Valve apparently registered for the trademark on September 29, 2013, and its currently listed as Computer game software; Electronic game software; Downloadable computer game software via a global computer network and wireless devices; Video game software.. While the trademark appears to be official, Valves actual motivation remains in question. Is Valve actually taking the next step in developing Half-Life 3 or are they merely trying to protect their IP?. Things certainly just got a whole lot more interesting!. ...
Passage of America Invents Act Brings Drastic Changes to U.S. Patent System | Buchanan Ingersoll & Rooney PCPassage of America Invents Act Brings Drastic Changes to U.S. Patent System | Buchanan Ingersoll & Rooney PC
Section 3 of the Act changes the United States patent system from a "first to invent" system to a "first inventor to file" system. This results in several significant changes to obtaining a patent in this country. First, there is no longer a one year grace period for filing a patent application and any patent or printed publication, or public use or offer for sale, up to the filing date of the application, can act as a bar. As an additional change, the public use or offer for sale activities that serve as a bar can occur anywhere in the world. One significant exception in the new system is that disclosures made by the inventors themselves, or any disclosure based on information obtained from the inventors, will not act as a bar to a patent if the patent application is filed within one year from the date of the disclosure. This section will become effective 18 months from the date of enactment of the bill (i.e., March 16, 2013) and will apply only to applications filed with a priority date after ...
CTPLO | China Trademark & Patent Law Office 中国知识产权 | CTPLO Trademark ClassificationCTPLO | China Trademark & Patent Law Office 中国知识产权 | CTPLO Trademark Classification
CTPLO - China Trademark & Patent Law Office. Peoples Republic of China. 中华人民共和国国家工商行政管理总局商标局 China Trademark Office (CTMO)
1 - United states patent and trademark office trademark electronic search system1 - United states patent and trademark office trademark electronic search system
Leaps trading strategies pdf #### UNITED STATES PATENT AND TRADEMARK OFFICE TRADEMARK ELECTRONIC SEARCH SYSTEM Macam mana nak mula forex #### Kerridge motor trade systems
1 - Patent and trademark offices trademark electronic search system1 - Patent and trademark offices trademark electronic search system
Binary options books amazon #### PATENT AND TRADEMARK OFFICES TRADEMARK ELECTRONIC SEARCH SYSTEM Trading and investment strategies in behavioral finance #### Forex widget
Google Answers: AIDS Drug PatentGoogle Answers: AIDS Drug Patent
Dear minarah, The U.S. Patent and Trademark Office issued the patent for the antiviral combination of the two active ingredients lamivudine and zidovudine, branded as Combivir, on 12 January 1999. The patent number is 5,859,021. The U.S. trademark Combivir for that drug was applied for by Glaxo Group Limited on 20 February 1997 and registered by the Trademark Office on 19 May 1998. Combivir was launched in the USA on 26 September 1997. Hope this answers your question! Regards, Scriptor Sources: M decins Sans Fronti res: Annexes (PDF file) http://www.accessmed-msf.org/upload/ReportsandPublications/492001113146/Annexes.pdf GalaxoSmithKline: Annual Report - Intellectual Property http://www.gsk.com/financial/reports/ar/report/descrip_of_bus/intell_property/intell_prop.html United States Patent and Trademark Office: Patent Database http://patft.uspto.gov/netahtml/PTO/search-bool.html United States Patent and Trademark Office: Trademark Database ...
CURRAX Trademark of Currax Pharmaceuticals LLC. Serial Number: 88363434 :: Trademark Elite TrademarksCURRAX Trademark of Currax Pharmaceuticals LLC. Serial Number: 88363434 :: Trademark Elite Trademarks
CURRAX is a trademark and brand of Currax Pharmaceuticals LLC, , 10 North Park Place, Suite 201 Morristown , NJ . This trademark was filed to USPTO on Friday, March 29, 2019. The CURRAX is under the trademark classification: Pharmaceutical Products; The CURRAX trademark covers Full line of medical, pharmaceutical, and therapeutic preparations for use in connection with humans
Q&A With Sandra Park About Upcoming Gene Patent Case | Breast Cancer ActionQ&A With Sandra Park About Upcoming Gene Patent Case | Breast Cancer Action
We asked Sandra Park, a staff attorney with the ACLU Womens Rights Project and one of the lead attorneys on our legal challenge to Myriad Genetics patents on the "breast cancer genes," to answer a few questions about this landmark case. The case is The Association of Molecular Pathology, et al v. Myriad Genetics and will be heard by the Supreme Court on April 15th. Breast Cancer Action is the only breast cancer organization that is a plaintiff in this case. 1. Why did the ACLU decide to take on a legal challenge to human gene patents?. This is the first patent case ever brought by the ACLU, so we studied the issue closely and consulted with many people before deciding to get involved. Ultimately, we realized that gene patents, and the policy of the U.S. Patent and Trademark Office of granting these patents, must be challenged because of the important civil liberties concerns they raise. Gene patents stand in the way of scientific innovation and medical care because they allow the patent holder ...
Overview of Trademark LawOverview of Trademark Law
1. What is a trademark?. A trademark is a word, symbol, or phrase, used to identify a particular manufacturer or sellers products and distinguish them from the products of another. 15 U.S.C. 1127. For example, the trademark "Nike," along with the Nike "swoosh," identify the shoes made by Nike and distinguish them from shoes made by other companies (e.g. Reebok or Adidas). Similarly, the trademark "Coca-Cola" distinguishes the brown-colored soda water of one particular manufacturer from the brown-colored soda of another (e.g. Pepsi). When such marks are used to identify services (e.g. "Jiffy Lube") rather than products, they are called service marks, although they are generally treated just the same as trademarks.. Under some circumstances, trademark protection can extend beyond words, symbols, and phrases to include other aspects of a product, such as its color or its packaging. For example, the pink color of Owens-Corning fiberglass insulation or the unique shape of a Coca-Cola bottle might ...
ZONORCE Trademark of Takeda Vaccines, Inc.. Serial Number: 88323587 :: Trademark Elite TrademarksZONORCE Trademark of Takeda Vaccines, Inc.. Serial Number: 88323587 :: Trademark Elite Trademarks
ZONORCE is a trademark and brand of Takeda Vaccines, Inc., , One Takeda Parkway Deerfield , IL . This trademark was filed to USPTO on Sunday, March 3, 2019. The ZONORCE is under the trademark classification: Pharmaceutical Products; The ZONORCE trademark covers Vaccines for human use
Reactification of Trademark & Patent.. - Intellectual Property RightsReactification of Trademark & Patent.. - Intellectual Property Rights
Dear All Pls provide me a copy of draft petition of Rectification of Trademark Patent before the Registrar IPAB With Regards - Intellectual Property Rights
UAH - OTC - For UAH Inventors - GlossaryUAH - OTC - For UAH Inventors - Glossary
Applicant: An inventor or joint inventors who apply for a patent of their own invention, or the person who applies for a patent in place of the inventor.. Board: The Board of Trustees of the University of Alabama.. Co-inventor: An inventor who is named with at least one other inventor in a patent application, in which each inventor contributes an idea to the conception of the invention that gives rise to at least one claim in the patent.. Commercialization: The process of preparing intellectual property (IP) for exploitation in the marketplace. Steps in the process include IP disclosure to the UAH Office of Technology Commercialization (OTC), assessment for patentability, patent prosecution, marketing, and licensing.. Conception: The time at which an inventor first thinks of an idea. A written document such as a well-maintained lab notebook is required to establish proof of a date of conception.. Confidentiality Agreement: A document in which a party agrees not to disclose proprietary ...
Contract Corner: US Intellectual Property Ownership - Default LawsContract Corner: US Intellectual Property Ownership - Default Laws
Protecting intellectual property rights is a critical component to the success of a technology company. In order for a tech company to determine how to protect its intellectual property, the company should understand how the key intellectual property rights work. In this Part 1 of a three-part series, we discuss how patent, copyright, and trade secret ownership works in the United States if there is no agreement in place to allocate these rights.. Patents Patents are a right to exclude others from using a technology for a limited period of time. In exchange for these rights, the patent holder must disclose the invention in the patent. Without an agreement in place to state the ownership of an invention that is patented, the following applies: ...
March 2014 - PEAH - Policies for Equitable Access to HealthMarch 2014 - PEAH - Policies for Equitable Access to Health
Ministry of Health & Family Welfare), New Delhi. Introduction It is widely believed that pharmaceutical patents promote monopoly and thus significantly delay the entry of generics. Due to the lack of competition, the prices of medicines rise. The current system of product patent protection due to the harmonized global intellectual property rights laws are widely considered to be a major barrier for the access to medicines, especially in the developing countries.1 [1] Until such a time the poor and middle income countries became signatories to the World Trade Organization s 1995 Trade Related Intellectual Property Rights (TRIPS) agreement, they had the freedom and flexibility to design patent laws that prohibited product patents. With the enforcement of the TRIPS agreement in 2005, developing countries have been compelled to modify and introduce TRIPS-compliant national patent laws. The TRIPS Agreement harmonized the life of patent to a minimum of 20 years besides mandating the granting of ...
Symposium: The cacophony of trademarks is not government speech - SCOTUSblogSymposium: The cacophony of trademarks is not government speech - SCOTUSblog
Justice Samuel Alito does not mince words on this topic in rejecting the claim that trademarks are a form of government speech, writing: "If the federal registration of a trademark makes the mark government speech, the Federal Government is babbling prodigiously and incoherently." He goes on to list trademarked statements that would represent dubious advice on the part of the government (such as "make.believe" by Sony), and juxtaposes marks with contradictory statements (like "Capitalism Is Not Moral, Not Fair, Not Freedom" and "Capitalism Ensuring Innovation"). Alito explains how the world of trademarks cannot be likened to other forms of government speech in which the state seeks to promote a specific message, such as the encouragement of beef-product consumption at issue in Johanns v. Livestock Marketing Association. It is noteworthy that all the justices joined this part of the opinion.. As Alitos opinion recognizes, the claim that trademarks by necessity bear a form of government ...
COPYRIGHTS AND TRADEMARKS - Itamar MedicalCOPYRIGHTS AND TRADEMARKS - Itamar Medical
The materials on this web site belong to or are licensed to us. The materials are protected by United States and foreign copyright laws. There are some important rules about copying these materials. You may e-mail, download, or print copies of the materials on this web site, but only for your personal, noncommercial use. When you e-mail, download, or print a copy of the materials on this web site, you must also include all copyright and other notices that are in the materials, including the copyright notice on the bottom of the page.. We also own the names we use for our products and services on this web site, and these names are protected by United States and foreign trademark laws. An ® following a name on our web site indicates that the trademark has been registered in the United States. A ™ following a name on our web site indicates that it is an unregistered trademark. All trademarks are the property of their respective owners.. There may be special rules for the use of materials ...
Intellectual Property - DigniCap Scalp Cooling SystemIntellectual Property - DigniCap Scalp Cooling System
Dignitana, DigniCap and DigniLife are registered trademarks owned by Dignitana AB (publ).. The below list of trademarks registered by Dignitana is regularly checked and updated, but it cannot be considered an exhaustive list of the trademarks registered by Dignitana. The absence of any trademark from the list below does not constitute a waiver of Dignitanas trademark or other intellectual property rights with respect to that trademark.. Dignitana ...
Groklaw - SCOs Missing Risk FactorGroklaw - SCO's Missing Risk Factor
l) Intellectual Property. Each of the Company and its Subsidiaries owns or is duly licensed (and, in such event, has the unfettered right to grant sublicenses) to use all patents, patent applications, trademarks, trademark applications, trade names, service marks, copyrights, copyright applications, licenses, permits, inventions, discoveries, processes, scientific, technical, engineering and marketing data, object and source codes, know-how (including trade secrets and other unpatented and/or unpatentable proprietary or confidential information, systems or procedures) and other similar rights and proprietary knowledge (collectively, Intangibles ) necessary for the conduct of its business as now being conducted and as presently contemplated to be conducted in the future. Section 3(l) of the Disclosure Schedule sets forth a list of all material patents, patent applications, trademarks, trademark applications, copyrights, licenses, sublicenses, and copyright applications owned and/or used by the ...
Organic (e.g., Chemical Warfare Agents, Insecticides, Etc.) Patents and Patent Applications (Class 436/104) - Justia Patents...Organic (e.g., Chemical Warfare Agents, Insecticides, Etc.) Patents and Patent Applications (Class 436/104) - Justia Patents...
Search for Organic (e.g., Chemical Warfare Agents, Insecticides, Etc.) Patents and Patent Applications (Class 436/104) Filed with the USPTO
January 15, 2013 - Weeding the GemsJanuary 15, 2013 - Weeding the Gems
Frances Salisbury is a Patent Attorney at Mewburn Ellis LLP. She has a PhD from University of Edinburgh, where she researched the role of phytochrome photoreceptors in root development in Arabidopsis thaliana. She agreed to guest post on intellectual property rights in plant science - enjoy! Patents and other intellectual property rights can be a controversial topic in the area of plant research, and much confusion exists about what protection is available, whether such work should be protected, and how this impacts on academic research. In this article, I hope to provide a very brief introduction to some of the different intellectual property rights that are available for plant research, particularly thinking about aspects that might be protectable by a patent.. So, why would you want to protect your plant research? Essentially, licensing and selling intellectual property rights can be used to create revenue for future research, or might be exchanged for the right to use other peoples ideas ...
Current Level of the Agreed IP Protection under the WTOs TRIPS AgreementCurrent Level of the Agreed IP Protection under the WTO's TRIPS Agreement
Though it also endows with for the endorsement of definite safeguards, for instance, utilization of copyrights by governments, obligatory licensing, corresponding imports, and other exceptions to exceptionality rights, that be capable of void or restrict the privileges of patent holders in certain circumstances. In actuality, such procedures have been established by developed countries in array to stabilize intellectual property rights with the communal interest, encouraging contest and shielding consumers.Intellectual property rights are a state-created union that is specified to the persons or trade houses over the notion of their intellects. The United Kingdom carries out a realistic, prudent, and transparent loom towards backing up industries to shield their IPR. The key organization responsible for overseeing IPR in the UK (including patents, trademarks, designs, and copyright) is the "UK Intellectual Property Office." The key aspects covered for the protection of Intellectual property in ...
Supreme Court Overturns CAFC Yet Again; Explains Basic Patent Law To The Patent Court | TechdirtSupreme Court Overturns CAFC Yet Again; Explains Basic Patent Law To The 'Patent' Court | Techdirt
Over the last few years, the Supreme Court has taken a renewed interest in patent law. After years of ignoring the issue, and leaving it in the hands of the appeals court for the federal circuit (CAFC -- which was established, in part, to hear all patent appeals), the Supreme Court has taken to regularly smacking down the CAFC, and telling it that it doesnt understand basic patent law. Its now happened again. The court has reversed yet another CAFC decision, this time concerning who has the burden of proving infringement. This was as case involved Medtronic filing for a declaratory judgment that it did not infringe on someone elses patent (Medtronic, it should be noted, has a history of being quite a patent bully itself at times). A district court had noted that the patent holder, in this case the Mirowski Family Ventures, has the burden of proof on showing infringement. CAFC said that since Medtronic brought the declaratory judgment suit that it was actually Medtronics burden to prove that ...
US patent office rules that artificial intelligence cannot legally be an inventor - The Verge | Robot Labor ForceUS patent office rules that artificial intelligence cannot legally be an inventor - The Verge | Robot Labor Force
The patents were submitted last year by the Artificial Inventor Project. Along with the patents submitted to the USPTO, the team also submitted documents to the UKs Intellectual Property Office (IPO) and the European Patent Office (EPO). The IPO and EPO have already ruled that DABUS, which was created by AI researcher Stephen Thaler, cannot be listed as an inventor based on similar legal interpretations. The USPTO asked the public for opinions on the topic last November. The Artificial Inventor Project is not arguing that an AI should own a patent, just that it should be listed as an inventor, MIT Technology Review notes. It argues that this might be necessary when hundreds or even thousands of employees have contributed code to a system, like IBMs Watson supercomputer, before the computer itself then goes on to solve a problem. If no human was involved closely enough with an invention to claim credit for it, then the group fears it may be impossible to patent it at all.. The project also ...
Concern Erupts Over WTO System And Medicines Shipments; TRIPS Talks Rekindling - Intellectual Property WatchConcern Erupts Over WTO System And Medicines Shipments; TRIPS Talks Rekindling - Intellectual Property Watch
The ambassadors to the World Trade Organization from Brazil and India on Tuesday charged that other WTO members had no grounds to block legitimate shipping of generic medicines on the basis of potential intellectual property rights conflicts in the transit country and said recent cases of doing so in the Netherlands call into question WTO rules. The concern was supported by 17 other developing country governments at Tuesdays WTO General Council meeting.. Meanwhile, the ambassadors of Brazil, India, the European Union and Switzerland are expected to meet on Wednesday, according to an official, to discuss ways to start negotiating within the WTO on a proposal to extend higher name protection wines and spirits enjoy to geographical indications on other products, and on a proposal to amend WTO rules on intellectual property rights to require the disclosure of origin of genetic material in patent applications. Over 100 WTO members have called for these topics to be negotiated but a smaller number ...
Africa: A trademark judgment that will please multinationals | Managing Intellectual PropertyAfrica: A trademark judgment that will please multinationals | Managing Intellectual Property
There were two interesting trademark judgments in Mauritius recently. Although these judgments do not contain any groundbreaking law, they do highlight how keen the Mauritian authorities are to attract foreign investment. Part of this process seems to involve making trademark protection and enforcement easily accessible. One way of doing that is to follow foreign precedents closely, particularly UK and European authorities.. The judgments in the cases of Shangri-La Tours Ltd v Shangri-La International Hotel Management Limited and the Controller of Industrial Property Office, October 14 2019, were decisions of the Industrial Property Tribunal. They involved applications by a local company to cancel various trademark registrations belonging to a foreign company. The Tribunal found against the local company, refusing to cancel the registrations of the foreign company. A number of aspects are worth noting:. ...
Opinion on Release Issue - Intellectual Property Rights: Open Access Volume 4 Issue 1 | OMICS InternationalOpinion on Release Issue - Intellectual Property Rights: Open Access Volume 4 Issue 1 | OMICS International
Intellectual Property Rights: Open Access (ISSN: 2375-4516) provides Tri-annual publication of articles in all areas related to the fields of Copyrights, Intellectual Pro..
Knowledge diffusion from FDI and Intellectual Property RightsKnowledge diffusion from FDI and Intellectual Property Rights
We study the extent to which a countrys strength of Intellectual Property Rights (IPR) protection mediates knowledge spillovers from Foreign Direct Investment (FDI). Following the opposing views in the IPR debate, we propose a negative effect of IPR strength on unintentional horizontal (intra-industry) knowledge diffusion. Using a unique firm-level dataset of large, publicly traded firms in 22 (mostly) developed countries, we find partial support for these expectations. Strong IPR indeed reduces horizontal knowledge diffusion, while it stimulates backward (to suppliers) knowledge diffusion. Somewhat unexpectedly however, we also find that forward (to customers) knowledge diffusion decreases with IPR strength. In general, and in line with earlier literature, the results regarding backward knowledge diffusion are most robust to changes in model specification. Our results contribute to the debate regarding the desirability of strengthening national IPR systems, and suggest that local firms might indeed
Ligand divests Promacta intellectual property rights to Royalty PharmaLigand divests Promacta intellectual property rights to Royalty Pharma
Ligand Pharmaceuticals has agreed to sell the intellectual property rights associated with the thrombocytopenia drug Promacta to Royalty Pharma for $827m
Indigenous Intellectual Property RightsIndigenous Intellectual Property Rights
HADIH and WELCOME to the Union of BC Indian Chiefs Email Distribution List as part of our February 2000 conference, Protecting Knowledge: Traditional Resource Rights in the New Millennium. The purpose of this list is provide information relating to Indigenous Intellectual Property Rights/Traditional Resource Rights articles, news items and reports in the areas of culture and heritage. Our website contain links to other sites and you can access and/or download papers relating to the theme. Visit http://www.ubcic.bc.ca/Resources/conferences/PK.htm
ICE highlights dangers of illegal decorative contact lenses - National Intellectual Property Rights Coordination CenterICE highlights dangers of illegal decorative contact lenses - National Intellectual Property Rights Coordination Center
The operation, which is coordinated through the HSI-led National Intellectual Property Rights Coordination Center (IPR Center), has resulted in the seizure of over 20,000 pairs of counterfeit and decorative contact lenses ...
01PacRimLPolyJ281] Special 301: An Effective Tool Against Thailands Intellectual Property Violations01PacRimLPolyJ281] Special 301: An Effective Tool Against Thailand's Intellectual Property Violations
Abstract: Special 301 of the 1988 Omnibus Trade and Competitiveness Act grants the United States Trade Representative the authority to target countries that do not adequately protect intellectual property rights. The USTR has been investigating and negotiating with several countries, including Thailand, in an effort to improve intellectual property protections for American products. As a result, Thailand has instituted noteworthy changes in its copyright and patent laws. This Comment recommends that the USTR continue to negotiate with Thailand, and that the USTR continue to exert pressure on Thailand. This Comment also suggests that because Thailand has taken steps to improve protection of intellectual property rights, the USTR should refrain from imposing any trade sanctions under Special 301 against Thailand at this time ...
US Patent Application for Method for left atrial appendage occlusion Patent Application (Application #20050004652 issued...US Patent Application for Method for left atrial appendage occlusion Patent Application (Application #20050004652 issued...
Disclosed is an occlusion device for use in a body lumen such as the left atrial appendage. The occlusion device includes an occlusion member and may also include a stabilizing member. The stabilizing member inhibits compression of the left atrial appendage, facilitating tissue in-growth onto the occlusion member. Methods are also disclosed.
Article: Biotechnology, Patent Law and Piracy, vol. 7.5Article: Biotechnology, Patent Law and Piracy, vol. 7.5
Notes 1. Centre for Intellectual Property Law, Molengraaff Institute for Private Law, Utrecht University, the Netherlands. This paper is based on a presentation held at the Ius Commune Research School workshop on Intellectual Property at Edinburgh University School of Law, 19-20 June 2003. Reactions are most welcome. 2. Convention on Biodiversity, 1993, available at ,http://www.biodiv.org,. The Agreement on Trade-Related Aspects of Intellectual Property Rights, 1994; Marrakesh Agreement Establishing the World Trade Organization, Annex 1 C, Legal Instruments - Results of the Uruguay Round, available at ,http://www.wto.org/english/docs_e/legal_e/final_e.htm,. 3. M. Weatherall, In Search of a Cure: A History of Pharmaceutical Discovery, Oxford University Press, 1990, p. 3. Aboriginals seem to have had modified organisms for at least 100,000 years. See D. Posey, Commodification of the Sacred through Intellectual Property Rights, Journal of Ethnopharmacology (83), 2000, p. 6. 4. P. Rabinow, Making ...
Intellectual Property - AMBIZLAWIntellectual Property - AMBIZLAW
The world economy is becoming more and more reliant on innovations, and effective protection and enforcement of intellectual property (IP) rights is becoming more critical than ever for businesses to maintain a competitive edge. We represent many established multinational as well as early-stage companies, especially in the biotech, pharmaceutical and medical device space, in protecting their intellectual property rights. We assist our clients in discovering patentable inventions, preparing, filing and prosecuting patent applications, negotiating patent licensing agreements, conducting IP due diligence, (non)infringement and freedom-to-operate studies, and litigate intellectual property disputes in courts. Our team of IP professionals are veterans in their fields and provide sophisticated and sensible IP solutions to our clients at sensible costs.. #accordion-1986-1 .fusion-panel:hover, #accordion-1986-1 .fusion-panel.hover{ background-color: #ffffff } #accordion-1986-1 .fusion-panel { ...
Alcohol Trademarks of the 1800s: California Uncorks the Past | Trademark and Copyright LawAlcohol Trademarks of the 1800's: California Uncorks the Past | Trademark and Copyright Law
For the last two years, we have published the Trademark Year in Wine and Beer, a catalogue of each years trademark disputes in the alcoholic beverage industry.
MUSTADO Trademark of CHIROFIT Chiropractic Group LLC. Serial Number: 87145016 :: Trademarkia TrademarksMUSTADO Trademark of CHIROFIT Chiropractic Group LLC. Serial Number: 87145016 :: Trademarkia Trademarks
MUSTADO is a trademark and brand of CHIROFIT Chiropractic Group LLC. Filed to USPTO On Friday, August 19, 2016, The MUSTADO covers Medical clinic providing weight loss solutions, services and programs, nutrition counseling, hormone therapy, including, bioidentical hormone replacement, anti aging therapy, and natural hormone therapy, medical aesthetic procedures, including, laser hair removal, laser peels, botulinum toxin treatments, microdermabrasion, liposuction, vein treatments, vein therapy, cellulite treatments, body contouring treatments, injectable filler treatments, facials, and skin care. Search for other trademarks at Trademarkia.
EROTIC PERFORMER LAS VEGAS Trademark of Jusinto, Raul. Serial Number: 87143880 :: Trademarkia TrademarksEROTIC PERFORMER LAS VEGAS Trademark of Jusinto, Raul. Serial Number: 87143880 :: Trademarkia Trademarks
EROTIC PERFORMER LAS VEGAS is a trademark and brand of Jusinto, Raul. Filed to USPTO On Friday, August 19, 2016, The EROTIC PERFORMER LAS VEGAS covers Exotic dancing services. Search for other trademarks at Trademarkia.
The Rockefeller University » Intellectual property on pediatric cancer is dedicated to the publicThe Rockefeller University » Intellectual property on pediatric cancer is dedicated to the public
Intellectual property resulting from the discovery of specific DNA mutations linked to a rare and often deadly type of adolescent liver cancer, fibrolamellar hepatocellular carcinoma, has been dedicated to the public by the institutions that made the discovery, The Rockefeller University ("Rockefeller") and the New York Genome Center ("NYGC"). The institutions made this unusual move in the hope of accelerating progress toward the delivery of diagnostics and therapies for the devastating disease.. The intellectual property was described in an international PCT patent application, "Fusion Proteins and Methods of Use Thereof," [PCT/US2014/057580] and is based on research described in the journal Science in February 2014. With todays dedication, scientists worldwide, whether working in academia or industry, are free to use the technology described in the patent application without proprietary constraints.. The research was initiated by Sanford Simon, professor and head of the Laboratory of Cellular ...
Patent Protection - Patents - Intellectual Property RightsPatent Protection - Patents - Intellectual Property Rights
I am an innovator and i have several patent ideas that i develop into prototypes however these prototypes i lend to some engineering students for submission of
Intellectual Property Forums - Deposing Patent Prosecution CounselIntellectual Property Forums - Deposing Patent Prosecution Counsel
The intellectual property law server provides general information on intellectual property law including patent, trademark, copyright and includes forums, related articles and comprehensive links .
DipharmaDipharma
Some products referred to in this list may be subject to patents held by third parties. Any products subject to any such patent or other intellectual property right are referred to in this list as an indication of our technical capabilities to manufacture. The reference to any product subject to any patent or other intellectual property right held by third parties is not intended to represent that we are able to sell or supply any such product, as the ability to do so is subject to any applicable patent or intellectual property right. ...
Brazil Takes Next Step Toward WTO Cross-Retaliation Against US - Intellectual Property WatchBrazil Takes Next Step Toward WTO Cross-Retaliation Against US - Intellectual Property Watch
Brazilian President Lula has adopted a measure to enable the suspension of Brazils obligations to protect intellectual property rights from the United States, which follows a World Trade Organization ruling of US non-compliance with WTO rules, according to an unofficial translation of the provisional Brazilian measure. The dispute arose between the United States and Brazil over US cotton subsidies. An August 2009 WTO arbitration report gave Brazil the right to use trade countermeasures against the US, and in specific circumstances to suspend intellectual property rights obligations (IPW, WTO/TRIPS, 7 September 2009).. The provisional measure, available here, was signed on 10 February by Lula. It has the force of law and was done to ensure that from a domestic legal standpoint, no problems could be encountered when IP rights are suspended according to the WTO ruling, according to a Brazilian source.. Article 2, item 4 of the measure gives a list of IP rights, such as patents, copyrights and ...
Home | Teleflex® | LMA®Home | Teleflex® | LMA®
The following are trademarks or registered trademarks of Teleflex Incorporated or its affiliates, in the US and/or other countries:. LMA Airway Management. Teleflex, the Teleflex logo, LMA, LMA Airway Management, LMA Better by Design, LMA Classic, LMA Classic Excel, LMA Evolution Curve, LMA Fastrach, LMA Flexible, LMA Gastro, LMA Guardian, LMA ProSeal, ProSeal, LMA Protector, LMA Supreme, LMA T-Bag, LMA T-Bag Plus, LMA Unique, LMA Unique Evo, Unique Evo and Cuff Pilot are trademarks or registered trademarks of Teleflex Incorporated or its affiliates in the US and/or other countries.. Atomization. Teleflex, the Teleflex logo, MAD, MADdy, MADgic, MADgic Airway, MAD Nasal and MADomizer are trademarks or registered trademarks of Teleflex Incorporated or its affiliates in the US and/or other countries.. Except as otherwise noted, Teleflex Incorporated or its affiliates is the owner of all the trademarks referred to on this website. All brands and names are the property of their respective owners. © ...
Reversing the IP Ratchet: Global Implications of the U.S. Supreme Courts Ruling in Myriad - CitizenVoxReversing the "IP Ratchet": Global Implications of the U.S. Supreme Court's Ruling in Myriad - CitizenVox
Co-authored by Adriana Benedict and Tiffany Jang. The U.S. Patent and Trademark Office (USPTO) and European Patent Office (EPO) have been granting patents on isolated human DNA since the early 1980s. Many countries have followed their lead.. More than three decades later, the U.S. has become the first country to reject the patent eligibility of isolated DNA following last weeks Supreme Court ruling in Assn of Molecular Pathology v. Myriad Genetics. Will its opinion have any global ripple effects?. The USPTO has promoted harmonization with its standards of patentability through training and technical assistance programs since 1985. USPTO patent standards have spread in part due to a partnership established between the USPTO, EPO and Japanese Patent Office (JPO) in 1983. As noted by the Australian Law Reform Commission, in 1988, these Trilateral Offices issued a joint statement explaining that. Purified natural products are not regarded as products of nature or discoveries because they do not in ...
KATOR Granted US Patent for Innovative Suture Anchor Technology - Surgical FrontiersKATOR Granted US Patent for Innovative Suture Anchor Technology - Surgical Frontiers
LOGAN, Utah, Nov. 9, 2015 /PRNewswire/ - KATOR, a start-up medical device company focused on advanced tissue-to-bone reattachment systems, announced today that the United States Patent and Trademark Office has recently granted the company a key patent related to its innovative suture anchor technology.. US Patent 9,131,937 entitled "Suture Anchor" is the first patent issued from an expanding intellectual property portfolio held by the company that includes additional pending US and international patent applications. The patent covers a novel suture anchor device that eliminates the need for knot tying and locks different portions of suture to different portions of the anchor. This platform technology enables much stronger surgical repair constructs than currently marketed suture anchors, enabling surgeons to achieve stronger tissue-to-bone repairs with fewer suture anchors.. KATOR is a medical device company incubated and currently operated by Surgical Frontiers.. About Surgical ...
Alphabet adds patent claim to Uber intellectual property theft lawsuitAlphabet adds patent claim to Uber intellectual property theft lawsuit
Alphabet Incs self-driving car unit Waymo on Friday added a new patent claim to its intellectual property lawsuit against Uber Technologies Inc and requested a preliminary injunction to stop the ride-sharing service from using what it says is proprietary information, a court filing showed.
Patent and Trademark Assets Related to Absorbable Surgical Adhesives and Sealants Owned by Cohera Medical Inc® to Sell on...Patent and Trademark Assets Related to Absorbable Surgical Adhesives and Sealants Owned by Cohera Medical Inc® to Sell on...
Patent and Trademark Assets Related to Absorbable Surgical Adhesives and Sealants Owned by Cohera Medical Inc® to Sell on February 25, 2019 in Private Auction Ocean Tomo Transactions has been retained to conduct a private auction for the global patent portfolio and trademark assets related to absorbable surgi...
Australia - Certain Measures Concerning Trademarks, Geographical Indications and Other Plain Packaging Requirements Applicable...Australia - Certain Measures Concerning Trademarks, Geographical Indications and Other Plain Packaging Requirements Applicable...
Request for the Establishment of a Panel by Indonesia [PDF 21 KB]. World Trade Organization. WT/DS467/15. 6 March 2014. (14-1346). Original: English The following communication, dated 3 March 2014, from the delegation of Indonesia to the Chairperson of the Dispute Settlement Body, is circulated pursuant to Article 6.2 of the DSU.. On 20 September 2013, the Government of Indonesia requested consultations with the Government of Australia pursuant to Article 4 of the Understanding on Rules and Procedures Governing the Settlement of Disputes (DSU), Article XXII of the General Agreement on Tariffs and Trade 1994 (GATT 1994), Article 64.1 of the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPs Agreement), and Article 14.1 of the Agreement on Technical Barriers to Trade (TBT Agreement) with respect to certain Australian laws and regulations that impose restrictions on trademarks, geographical indications, and other plain packaging requirements on tobacco products and ...
Peru-United States Trade Promotion AgreementPeru-United States Trade Promotion Agreement
Connecticut RiverConnecticut River
High-volume low-speed fanHigh-volume low-speed fan
List of Dewey Decimal classesList of Dewey Decimal classes
SunPassSunPass
Acoustic Doppler current profilerAcoustic Doppler current profiler
LY-404,039LY-404,039
Neuropeptide Y receptorNeuropeptide Y receptor
List of generic and genericized trademarksList of generic and genericized trademarks
1624 in science1624 in science
Ladder GolfLadder Golf
Karol PollakKarol Pollak
Otto Julius ZobelOtto Julius Zobel
Technology and CultureTechnology and Culture
List of chemical compounds with unusual namesList of chemical compounds with unusual names
Read-copy-updateRead-copy-update
Steven B. HaasSteven B. Haas
Samuel D. GehmanSamuel D. Gehman
Stockless anchorStockless anchor
Fritz AldingerFritz Aldinger
Peter Mitchell GrantPeter Mitchell Grant
AmfepramoneAmfepramone
David Carroll (physicist)David Carroll (physicist)
Engineering lawEngineering law
Mind mapMind map
Willy MarckwaldWilly Marckwald
Hamlins Wizard OilHamlin's Wizard Oil
SouJavaSouJava
William C. PfefferleWilliam C. Pfefferle
Ariosa v. SequenomAriosa v. Sequenom
CraniosynostosisCraniosynostosis
100,000,000 Guinea Pigs100,000,000 Guinea Pigs
User talk:JevansenUser talk:Jevansen
Trade unionTrade union
Alternative medicineAlternative medicine
List of political parties in ChinaList of political parties in China
Open-source-software movementOpen-source-software movement
Color balanceColor balance
Anti-reflective coatingAnti-reflective coating
Computer graphics (computer science)Computer graphics (computer science)
Cold fusionCold fusion
Data compressionData compression
Bhumibol AdulyadejBhumibol Adulyadej
Stop motionStop motion
Section 44 of the Constitution of AustraliaSection 44 of the Constitution of Australia
Cold Spring Harbor LaboratoryCold Spring Harbor Laboratory
Florence NightingaleFlorence Nightingale
Healthcare in CubaHealthcare in Cuba
BiodieselBiodiesel
John Meurig ThomasJohn Meurig Thomas
History of EnglandHistory of England
List of atheists in science and technologyList of atheists in science and technology
Vitamin CVitamin C
TeXTeX
MonopolyMonopoly
Solar cellSolar cell
Funding of scienceFunding of science
List of national leaders of the Peoples Republic of ChinaList of national leaders of the People's Republic of China
LoudspeakerLoudspeaker
AnatomyDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPsychiatry and PsychologyPhenomena and ProcessesDisciplines and OccupationsAnthropology, Education, Sociology and Social PhenomenaTechnology, Industry, AgricultureInformation ScienceNamed GroupsHealth CarePublication CharacteristicsGeographicals
Patents as TopicForamen Ovale, PatentHeart Septal Defects, AtrialIntellectual PropertyEmbolism, ParadoxicalSeptal Occluder DevicePatentsVascular PatencyInventionsEchocardiography, TransesophagealDrug IndustryPeriodicals as TopicCongresses as TopicLicensureCardiac CatheterizationTreatment OutcomeTextbooks as TopicAbstracting and Indexing as TopicLegislation, DrugReview Literature as TopicBiotechnologyProstheses and ImplantsUrachusBalloon OcclusionDuctus ArteriosusRandomized Controlled Trials as TopicBlood Vessel ProsthesisInfant, NewbornAngiographyFollow-Up StudiesGuidelines as TopicEvidence-Based MedicineTerminology as TopicBenchmarkingResearchProgrammed Instruction as TopicTime FactorsGraft Occlusion, VascularInfant, PrematureLigationRosaniline DyesDrugs, GenericAortographyInterviews as TopicCardiac Surgical ProceduresHeart AneurysmForamen OvaleEmbolismBlood Vessel Prosthesis ImplantationIbuprofenHerbals as TopicInfant, Premature, DiseasesPolytetrafluoroethyleneValsalva ManeuverSaphenous VeinUnited StatesEndarteritisAnastomosis, SurgicalResearch Support as TopicEmbolization, TherapeuticFemoral ArteryEchocardiographyPractice Guidelines as TopicBiomedical ResearchRetrospective StudiesFemoral VeinBookplates as TopicBroadsides as TopicIntracranial EmbolismHeart Septal DefectsStentsEchocardiography, Doppler, ColorBiosimilar PharmaceuticalsPatient Education as TopicClinical Trials as TopicPostoperative ComplicationsStrokeProsthesis DesignArterial Occlusive DiseasesVena Cava, InferiorUrachal CystTesticular HydroceleCurriculumPopliteal ArteryEconomic CompetitionArteriovenous Shunt, SurgicalMigraine with AuraVeinsWebcasts as TopicReoperationProspective StudiesMammary ArteriesInvestmentsTomography, X-Ray ComputedManuscripts as TopicMeta-Analysis as TopicEquipment DesignIndomethacinLawyersVascular Surgical ProceduresAneurysmHeart Defects, CongenitalPolyethylene TerephthalatesConstriction, PathologicRisk FactorsHeart SeptumTibial ArteriesDehumanizationEmpirical ResearchThrombosisRecurrenceHeart MurmursPharmaceutical PreparationsRadiography, InterventionalCommerce
Patent - WikipediaPatent - Wikipedia
U.S. Patent and Trademark Office Expands First Action Interview Pilot Program | Insights | Venable LLPU.S. Patent and Trademark Office Expands First Action Interview Pilot Program | Insights | Venable LLP
A Perspective on Verisigns Patent Application on Domain Name TransfersA Perspective on Verisign's Patent Application on Domain Name Transfers
Patent Applicant Withdraws Application of its Own Accord! | SpicyIPPatent Applicant Withdraws Application of its Own Accord! | SpicyIP
Federal Register :: Topics (CFR Indexing Terms) - Inventions and patentsFederal Register :: Topics (CFR Indexing Terms) - Inventions and patents
Patent US5815830 - Automatic generation of hypertext links to multimedia topic objects - Google PatentsPatent US5815830 - Automatic generation of hypertext links to multimedia topic objects - Google Patents
Star Wars Darth Vader Patent Dome BagStar Wars Darth Vader Patent Dome Bag
Cooking For Engineers :: View topic - Patent Pending?Cooking For Engineers :: View topic - 'Patent Pending'?
Related eBooks ::: Recent Patents and Topics on Imaging (Discontinued)Related eBooks ::: Recent Patents and Topics on Imaging (Discontinued)
Topic 4 - WIPOs Patent Landscape Reports on Pharmaceutical Topics (Ritonavir, Atazanavir and Vaccine Manufacturing)Topic 4 - WIPO's Patent Landscape Reports on Pharmaceutical Topics (Ritonavir, Atazanavir and Vaccine Manufacturing)
Online Abstract Submission ::: Recent Patents and Topics on Imaging (Discontinued)Online Abstract Submission ::: Recent Patents and Topics on Imaging (Discontinued)
Trying Patent Cases Under the New KSR Standard, PLI Hot Topic Briefing | WilmerHaleTrying Patent Cases Under the New KSR Standard, PLI Hot Topic Briefing | WilmerHale
US20090094233A1 - Modeling Topics Using Statistical Distributions - Google PatentsUS20090094233A1 - Modeling Topics Using Statistical Distributions - Google Patents
Intellectual Property Forums - Send Topic « Can I patent something like this?... » to a friend!Intellectual Property Forums - Send Topic « Can I patent something like this?... » to a friend!
US20030167252A1 - Topic identification and use thereof in information retrieval systems - Google PatentsUS20030167252A1 - Topic identification and use thereof in information retrieval systems - Google Patents
Intellectual Property Forums - Send Topic « PhD in Biochemistry switching to patent agent » to a friend!Intellectual Property Forums - Send Topic « PhD in Biochemistry switching to patent agent » to a friend!
Patent Docs: USPTO Seeks Topics for Quality Case Study Pilot ProgramPatent Docs: USPTO Seeks Topics for Quality Case Study Pilot Program
Hot Topics in the Parallel Universe of Patent Reexamination and Patent Litigation | Baker DonelsonHot Topics in the Parallel Universe of Patent Reexamination and Patent Litigation | Baker Donelson
Strengthening the Patent Attorneys System, Topic Discussed in a National SeminarStrengthening the Patent Attorneys System, Topic Discussed in a National Seminar
OUPower.com • View topic - Interesting Magnet Engine PatentOUPower.com • View topic - Interesting Magnet Engine Patent
Rickresource Rickenbacker Forum • View topic - Some interesting patentsRickresource Rickenbacker Forum • View topic - Some interesting patents
Hot Topics in Patent Law: The America Invents Act of 2011, and Therasense, Inc. v. Becton, Dickinson & Co. | Intelligence |...Hot Topics in Patent Law: The America Invents Act of 2011, and Therasense, Inc. v. Becton, Dickinson & Co. | Intelligence |...
PPT - Topics in Viral Immunology Bruce Campell Supervisory Patent Examiner Art Unit 1648 PowerPoint presentation | free to...PPT - Topics in Viral Immunology Bruce Campell Supervisory Patent Examiner Art Unit 1648 PowerPoint presentation | free to...
Patents, Trademarks Topic of eCenter Seminar - Business Journal Daily | The Youngstown Publishing CompanyPatents, Trademarks Topic of eCenter Seminar - Business Journal Daily | The Youngstown Publishing Company
Judge Invalidates Human Gene Patent - The New York TimesJudge Invalidates Human Gene Patent - The New York Times
Farks Drew Curtis Explains How To Beat A Patent Troll (And Live To Tell The Tale) | TechdirtFark's Drew Curtis Explains How To Beat A Patent Troll (And Live To Tell The Tale) | Techdirt
Patents | Encyclopedia.comPatents | Encyclopedia.com
SMIC settles patent suit with Taiwan Semi for $175M - MarketWatchSMIC settles patent suit with Taiwan Semi for $175M - MarketWatch
Digital Allys stock rocked after disappointing ruling in Axon patent dispute - MarketWatchDigital Ally's stock rocked after disappointing ruling in Axon patent dispute - MarketWatch
Patent Ductus Arteriosus | The BMJPatent Ductus Arteriosus | The BMJ
Knowledge Spillovers and Learning in the Workplace: Evidence from the U.S. Patent Office | NBERKnowledge Spillovers and Learning in the Workplace: Evidence from the U.S. Patent Office | NBER
Taiwans Asustek says company probe finds no patent infringement - MarketWatchTaiwan's Asustek says company probe finds no patent infringement - MarketWatch
Did Plant Patents Create the American Rose? | NBERDid Plant Patents Create the American Rose? | NBER
Patent on BRCA1 gene should never have been granted, researchers say | The BMJPatent on BRCA1 gene should never have been granted, researchers say | The BMJ
AnatomyDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPsychiatry and PsychologyPhenomena and ProcessesDisciplines and OccupationsAnthropology, Education, Sociology and Social PhenomenaTechnology, Industry, AgricultureInformation ScienceNamed GroupsHealth CarePublication CharacteristicsGeographicals
Patents as TopicForamen Ovale, PatentHeart Septal Defects, AtrialIntellectual PropertyEmbolism, ParadoxicalSeptal Occluder DevicePatentsVascular PatencyInventionsEchocardiography, TransesophagealDrug IndustryPeriodicals as TopicCongresses as TopicLicensureCardiac CatheterizationTreatment OutcomeTextbooks as TopicAbstracting and Indexing as TopicLegislation, DrugReview Literature as TopicBiotechnologyProstheses and ImplantsUrachusBalloon OcclusionDuctus ArteriosusRandomized Controlled Trials as TopicBlood Vessel ProsthesisInfant, NewbornAngiographyFollow-Up StudiesGuidelines as TopicEvidence-Based MedicineTerminology as TopicBenchmarkingResearchProgrammed Instruction as TopicTime FactorsGraft Occlusion, VascularInfant, PrematureLigationRosaniline DyesDrugs, GenericAortographyInterviews as TopicCardiac Surgical ProceduresHeart AneurysmForamen OvaleEmbolismBlood Vessel Prosthesis ImplantationIbuprofenHerbals as TopicInfant, Premature, DiseasesPolytetrafluoroethyleneValsalva ManeuverSaphenous VeinUnited StatesEndarteritisAnastomosis, SurgicalResearch Support as TopicEmbolization, TherapeuticFemoral ArteryEchocardiographyPractice Guidelines as TopicBiomedical ResearchRetrospective StudiesFemoral VeinBookplates as TopicBroadsides as TopicIntracranial EmbolismHeart Septal DefectsStentsEchocardiography, Doppler, ColorBiosimilar PharmaceuticalsPatient Education as TopicClinical Trials as TopicPostoperative ComplicationsStrokeProsthesis DesignArterial Occlusive DiseasesVena Cava, InferiorUrachal CystTesticular HydroceleCurriculumPopliteal ArteryEconomic CompetitionArteriovenous Shunt, SurgicalMigraine with AuraVeinsWebcasts as TopicReoperationProspective StudiesMammary ArteriesInvestmentsTomography, X-Ray ComputedManuscripts as TopicMeta-Analysis as TopicEquipment DesignIndomethacinLawyersVascular Surgical ProceduresAneurysmHeart Defects, CongenitalPolyethylene TerephthalatesConstriction, PathologicRisk FactorsHeart SeptumTibial ArteriesDehumanizationEmpirical ResearchThrombosisRecurrenceHeart MurmursPharmaceutical PreparationsRadiography, InterventionalCommerce
USPTOInventionApplicationTypes of patentsEligibleGeneticsApplicantsInventorsInnovationImplicationsSoftware patentsInventionsProsecutionScientistsEarliestTypicallyApplicationsExaminerProtectionDataStatutoryProcedureClaimsInventions2019Company'sLitigation2017Google'sLawsuits2001Microsoft'sNaturally occurHuman genesSearchViableSeven patentsAmerica Invents ActUniversitiesTrollsWidespreadDuctus ArteriosusResearchersBRCA1Regulations500,000WorthlessFlorian MuellerInventorsInvalidMotorola Mobility2016HoldersDefendantsCannabisClassificationsCourtsLicensesInnovationsConsortiumMethodologyViewIntellectual20002002Samsung'sTechnology patentsSuitsGeneCompaniesOwnershipSystemProcess1987RoyaltiesCase
USPTO1
Invention4
Application8
Types of patents1
Eligible1
  • The Pilot Program provides applicants who submit eligible U.S. patent applications with the opportunity to conduct an interview with the patent examiner after he or she conducts a prior art search, but before issuance of a first Office Action on the merits. (venable.com)
Genetics2
Applicants2
  • The Pilot Program gives applicants who submit certain patent applications the opportunity to conduct an interview with the patent examiner prior to issuance of a first Office Action on the merits. (venable.com)
  • Self-initiated steps taken by future patent applicants, such as the one taken in the present decision, will also go a long way in tackling the issue head-on. (spicyip.com)
Inventors1
  • This was incorporated into the Statute of Monopolies (1624) in which Parliament restricted the Crown's power explicitly so that the King could only issue letters patent to the inventors or introducers of original inventions for a fixed number of years. (wikipedia.org)
Innovation3
  • industrial design rights are called design patents in the US, plant breeders' rights are sometimes called plant patents , and utility models and Gebrauchsmuster are sometimes called petty patents or innovation patents . (wikipedia.org)
  • The choice of standard-essential patents (SEPs) is particularly suited because of the 'strategic' importance of such patents for China's indigenous innovation program. (tue.nl)
  • The choice of standard-essential patents (SEPs) is particularly suited because of the {\textquoteleft}strategic{\textquoteright} importance of such patents for China{\textquoteright}s indigenous innovation program. (tue.nl)
Implications1
Software patents1
Inventions1
Prosecution2
Scientists1
Earliest1
Typically1
Applications3
  • Which brings us to the issue of pendency in the Indian Patent Office: This issue is currently being effectively tackled by the Government and measures such as computerization of work-flow, automation, electronic transfer of applications between branches etc. have indeed led to a decline in the number of pending matters. (spicyip.com)
  • It focuses on the case of China and looks specifically at patent applications declared as essential to a technological standard. (tue.nl)
  • We find that patent applications by foreign firms are treated unfavorably when examiners know that they are declared as standard essential. (tue.nl)
Examiner2
  • If not, the patent examiner will issue a Pre-Interview Communication setting forth a one-month time period (extendible for thirty days under the enhanced program) during which the applicant may request or decline the interview. (venable.com)
  • If no agreement is reached, the patent examiner will issue a First Action Interview Office Action, to which the applicant must respond like a typical Office Action. (venable.com)
Protection3
  • Patents were systematically granted in Venice as of 1474, where they issued a decree by which new and inventive devices had to be communicated to the Republic in order to obtain legal protection against potential infringers. (wikipedia.org)
  • As Venetians emigrated, they sought similar patent protection in their new homes. (wikipedia.org)
  • We particularly address some of the neglected or seemingly arcane points that nevertheless are critical to the researcher, medical practitioner, scientist, or indeed anyone seeking informed opinions about patent protection of new biotechnologies and genetic technologies. (biomedcentral.com)
Data1
Statutory1
  • Although there is some evidence that some form of patent rights was recognized in Ancient Greece in the Greek city of Sybaris , the first statutory patent system is generally regarded to be the Venetian Patent Statute of 1474. (wikipedia.org)
Procedure1
  • The procedure for granting patents, requirements placed on the patentee, and the extent of the exclusive rights vary widely between countries according to national laws and international agreements. (wikipedia.org)
Claims3
Inventions16
  • The professional activity of patent attorneys consists in representing natural persons and legal entities or rendering the necessary assistance to them in the field of protection of intellectual property objects (geographical indications, appellations of origin and traditional specialties guaranteed, trademarks, inventions, industrial designs, plant varieties, topographies of integrated circuits). (agepi.md)
  • If the patent law is to protect novel and useful inventions, it must be determined just what should be regarded as an "invention" and what as "novel" and "useful. (encyclopedia.com)
  • How should priority be decided in cases of nearly simultaneous inventions: Should the patent go to him who was first in getting the idea, or to him who was first in putting it into patentable form, or to him who was first in submitting it to the patent office? (encyclopedia.com)
  • some make "improvement inventions" eligible only for supplementary "patents of addition" of shorter duration, terminating, for example, with the primary patent on the invention that they improve. (encyclopedia.com)
  • US Supreme Court decisions have raised substantial uncertainty around whether certain inventions are abstract ideas, laws of nature, or natural phenomenon, or contain sufficient additional elements to be patent eligible. (lexology.com)
  • Three recent Federal Circuit decisions, along with new updates from the USPTO, offer guidance on which steps to take in patenting healthcare IT-related inventions. (lexology.com)
  • Enfish suggests that narrowly drawn claims are more likely to pass patent eligibility muster than broader ones, sound advice for patenting algorithm-intensive inventions in the healthcare field. (lexology.com)
  • The recent Federal Circuit decisions and USPTO guidance suggest that inventions relating to abstract ideas, laws of nature, and natural phenomena may become patent eligible if applied in narrowly defined real-world terms, especially involving combinations of elements (subject to other patent laws requiring inventions to be novel and non-obvious) which lead to below-referenced outcomes or results. (lexology.com)
  • Interestingly, challenges on gene patents in Australia and Europe have all resulted in law in this area remaining unchanged, where new inventions relating to isolated biological materials, including genes, remain patentable. (dlapiper.com)
  • Even though the specific patent application before the Court was unanimously rejected, the boundaries of patent-eligible inventions remain uncertain. (fenwick.com)
  • This logic guided passage of the 1980 Bayh-Dole Act , which lets universities, small businesses and nonprofits own patents for inventions and discoveries that stem from federally funded research. (theconversation.com)
  • But if nonprofits and small businesses could patent the inventions they developed, then they could exclusively license these inventions and defuse the threat of competition. (theconversation.com)
  • These offices secure patents and then work to license the patented inventions and discoveries. (theconversation.com)
  • Well-known musicians and other entertainers often identify opportunities for innovation in their industry and are able to obtain patent protection for such inventions. (foster.com)
  • As the above examples illustrate, professional entertainers, through their own use of musical instruments and/or the need to enhance an act, saw a need for improved products and received patent protection for their inventions. (foster.com)
  • Probably the most successful was the anti-software-patent campaign in Europe that resulted in the rejection by the European Parliament of the Proposed directive on the patentability of computer-implemented inventions which, the free software community argues, would have made software patents enforceable in the European Union. (wikipedia.org)
20191
  • On August 21, 2019, the Government of Canada published amendments to the Patented Medicines Regulations that set out the long-awaited framework applicable to the price regulation of patented drugs in Canada. (mccarthy.ca)
Company's3
  • In other words, Facebook's view is that Facebook Messenger, Instagram, and WhatsApp were built on the company's own ideas rather than on BlackBerry's patents. (nasdaq.com)
  • The company's unwavering commitment to technology and protecting its R&D+i results, combined with the work of more than 730 researchers focused on developing and improving new technologies, has led to significant growth in the number of patents, which currently exceeds 220 applications and awards. (altenergymag.com)
  • Like all other patents, a filing doesn't mean that Microsoft is set to announce folding smartphone/tablet hybrids, nor does it mean a folding phone is even in the company's future. (techrepublic.com)
Litigation8
20172
  • On September 11, 2017, Amazon's most infamous patent expires -the "one-click patent" that allows Amazon to control the selling of goods to consumers with a single click. (teleread.org)
  • In comparison to 2017, China's share has increased by 11.6% which is greatly influenced by the factor of seeking patent protection from other corporations within the country. (jkpeterson.net)
Google's4
  • The Commission already issued a warning against Motorola Mobility's aggressive patent enforcement when it approved Google's acquisition of the cell phone maker in February. (salon.com)
  • That ban centered on European Patent EP2059868 , and pertained to Samsung's use of Google's stock Android 2.2.1 or later, which began copying the iPhone technique Apple invented to simplify the navigation and direct manipulation of photos, often referred to as simply the "bounce back" patent. (appleinsider.com)
  • Following its success in Germany, Google's efforts to attack Apple's invention in the U.S. serves as a tactic to reduce Samsung's nearly billion dollar penalty for infringing the patented invention in producing Galaxy phones designed to look and work identically to Apple's iPhone, beginning back in 2010. (appleinsider.com)
  • Google's previous efforts to "protect Android" from infringement claims originally centered around buying up billions of dollars worth of patents and using these to support its licensees after they were sued. (appleinsider.com)
Lawsuits8
20012
  • Using application-level data from the Patent Office from 2001 to 2012, merged with personnel data on patent examiners, we explore the extent to which the key decision of examiners-whether to allow a patent-is shaped by the granting styles of her surrounding peers. (nber.org)
  • The Association of University Technology Managers' annual licensing survey shows total university income from patents increasing from $699 million in 1997 to $1.07 billion in 2001. (technologyreview.com)
Microsoft's2
  • None of the patents are related to Microsoft's own online CRM software, the heart of the Salesforce offering. (zdnet.com)
  • However, the 2009 lawsuit against TomTom involved the use of Microsoft's patents for long filenames on FAT filesystems, the code for which was in the Linux kernel, not in any TomTom-developed software. (wikipedia.org)
Naturally occur2
  • Given that patents on full-length, naturally occurring genes with introns and exons will no longer be a barrier to entry for diagnostic companies, going forward the market will see more competition. (dlapiper.com)
  • By the end of 2000, 500,000 naturally occurring genes or DNA sequences were patented or patent-pending. (ourbeacon.com)
Human genes1
Search3
  • The invention relates generally to computerized information management technologies and, more particularly but not by way of limitation, to the generation of relevant domain-specific topics for a corpus of data to facilitate subsequent search and retrieval operations for the data. (google.com)
  • External Data Spec Patents in environment-related technologies Patent search strategies for various areas of 'environmental' technologies have been developed at OECD and have been used to produce the dataset. (europa.eu)
  • If they are actually patented, I would think that you could search for the actual patent. (homebrewersassociation.org)
Viable4
  • I own both of these stocks, and neither one would be a viable business without a usable patent protection system. (nasdaq.com)
  • The patent at issue claims a method of preparing frozen liver cells that can be thawed and re-frozen while remaining viable. (lexology.com)
  • None of the folks at Phylos really see patenting as a viable tool for the average breeder. (wweek.com)
  • You will need to reveal your product to others so begin a provisional patent as soon as you are confident your concept is viable. (qualitymag.com)
Seven patents2
  • In a 117-page complaint to the Central District Court of California, BlackBerry leans on seven patents to make its case against Facebook. (nasdaq.com)
  • Sonos alleges Lenbrook infringes on seven patents, including the two patents that D&M was found in a jury trial to have willfully infringed. (cepro.com)
America Invents Act2
Universities5
Trolls5
Widespread1
Ductus Arteriosus1
Researchers3
BRCA11
Regulations2
  • Below is a brief background on the Patented Medicine Prices Review Board (the "PMPRB" or the "Board"), four key changes to the Regulations , including differences from the originally proposed text, and developments to watch for regarding the amendments. (mccarthy.ca)
  • The Regulations currently do not specify any "other factors" under the Patent Act that the Board is required to consider. (mccarthy.ca)
500,0001
  • Right now there is a backlog of 620,000 pending patents with as many as 500,000 new patents filed every year, Lofgren said, so inventors can face a three-year wait for patent applications to be processed and approved or denied. (baselinemag.com)
Worthless2
  • In the U.S., Google argued on behalf of its Motorola Mobility subsidiary that Apple's patents should be ignored as worthless even as it distributed copies of Android that purposely emulated a variety of original elements of the iPhone that it knew to be patented. (appleinsider.com)
  • Motos patents have been worthless in their fight against suits. (osnews.com)
Florian Mueller2
  • But according to Florian Mueller of FOSS Patents , the company from the Valencia region of Spain successfully defended itself from accusations of infringing upon the design-related patent. (appleinsider.com)
  • Florian Mueller, the founder of an anti-patent Web site , said he is concerned that despite this change in voting weights the EU Council is still pushing ahead a decision. (zdnet.com)
Inventors1
  • The Court observed that the modern age allows more and more people to innovate, thus posing a challenge for patent law to strike the balance between protecting inventors and avoiding inappropriate monopolies. (fenwick.com)
Invalid5
Motorola Mobility3
  • BRUSSELS (AP) - The European Union's competition watchdog on Tuesday opened two investigations into whether Motorola Mobility, which is being bought by Google, is unfairly restricting competitors from accessing essential patents. (salon.com)
  • Motorola Mobility holds patents that are essential for standards linked to 2G and 3G mobile telecommunications, compressing video for online use, as well as wireless LAN technologies. (salon.com)
  • In its complaint against Motorola Mobility, Microsoft claimed that the cell phone maker was demanding excessively high prices for using some of its key patents. (salon.com)
20162
  • Written topic submissions must be received by the Office on or before February 12, 2016 to be considered. (patentdocs.org)
  • The company filed a 105-page complaint against networking hardware company Avaya in 2016, using a much more technical and less common-sense slate of eight patents. (nasdaq.com)
Holders3
  • In issuing the patent, the U.S. Patent Office acknowledged Litetronics' proprietary one-piece "rail system" which includes LED lamps, drivers, connecting wire and rare-earth magnetic holders. (thomasnet.com)
  • As with those successful models, the RFID consortium is intended to provide a structured approach for holders of essential RFID patents to receive fair compensation for those patents, at a reasonable cost to the end-user, thus promoting rapid adoption of RFID. (consortiuminfo.org)
  • What pharmaceutical company is going to develop a treatment whose success means having to pay out its profits as royalties to a slew of patent holders? (ourbeacon.com)
Defendants3
Cannabis2
  • A Portland biotechnology company has launched a 3-D map that charts the genetic evolution of cannabis genomes, protecting strains like OG Kush from future patent attempts by big agricultural companies such as Monsanto. (wweek.com)
  • NanoSphere Health Sciences (CSE:NSHS) (OTC: NSHSF) has been awarded a breakthrough patent, granting the biotech innovator full ownership over the standardized delivery of cannabis into systemic circul. (bioportfolio.com)
Classifications4
  • A technique to determine topics associated with, or classifications for, a data corpus uses an initial domain-specific word list to identify word combinations (one or more words) that appear in the data corpus significantly more often than expected. (google.com)
  • Topics may be used to guide information retrieval and/or the display of topic classifications during user query operations. (google.com)
  • In its database on 'Patents by technology' the OECD identifies 9 primary groups of technology based patent classifications one of which is defined as Selected environment-related technologies. (europa.eu)
  • Data for the primary area Selected environment-related technologies was downloaded along with data for Total patents (including all primary classifications). (europa.eu)
Courts5
  • In fact, many in the patent field had predicted the courts would throw out the suit. (nytimes.com)
  • Under the registration system the validity of a registered patent is examined only if an interested party attacks it in the courts and asks that the patent be invalidated. (encyclopedia.com)
  • Under the Supreme Court's ruling, a patent owner will now only be entitled to bring suit in federal courts having jurisdiction over a state where the defendant is either incorporated, or has a regular and established business and is also engaging in infringing activity. (consortiuminfo.org)
  • The patent could also be interpreted by the courts to cover any other elements (e.g. e-commerce engine, card systems, ERP connectors) that integrate with the basic system. (jarche.com)
  • Essa may have a point that the patent could be given wider application by the courts, but I'm not a patent lawyer or a judge. (jarche.com)
Licenses2
  • Plaintiff admits that the average license fees have been between $10,000 and $25,000, but argues that they properly reflect "the uncertainties of the ever-evolving § 101 jurisprudence and the value of previous licenses granted under the Patents-in-Suit to similarly situated [d]efendants. (techdirt.com)
  • Non-exclusive" allows the university to sell multiple licenses on a single patented invention. (theconversation.com)
Innovations7
Consortium3
Methodology2
  • According to the Office's Federal Register notice, case study topics submitted under the new pilot program should be more than mere statements of an issue or problem encountered by the submitter, but should propose a specific correlation or trend for study, and where possible, suggest a methodology for its investigation. (patentdocs.org)
  • Furthermore, international patents enable growth in cutting-edge markets in a globalized world, following a proprietary methodology of prioritizing patents and regions according to their potential. (altenergymag.com)
View4
  • Patent Term Adjustment Reductions in View of the Federal Circuit Decision in Supernus Pharm. (federalregister.gov)
  • Axon misled this Court and convinced the judge to take an overly narrow view of our patent,' said Digital Ally Chief Executive Stanton Ross. (marketwatch.com)
  • On January 9, 2015, the Federal Register published final rules implementing changes to patent term adjustment (PTA) in view of Novartis v. Lee , which the Federal Circuit decided last January. (mintz.com)
  • As I mentioned in my initial post on this patent , my view is that Blackboard's patent is for an "education" system, not a learning system. (jarche.com)
Intellectual4
20001
  • In 2000, 34,000 new patents listing at least one gene or sequence, and usually more than one, were filed each month. (ourbeacon.com)
20021
  • Brando was granted a series of patents beginning in 2002 directed to a "Drumhead Tensioning Device and Method. (foster.com)
Samsung's1
Technology patents1
  • This week, BlackBerry sued Facebook (NASDAQ: FB) for infringing on seven technology patents, asking the social network to shut down all three of its popular messaging apps. (nasdaq.com)
Suits2
Gene8
  • He said that many critics of gene patents considered the idea that isolating a gene made it patentable "a 'lawyer's trick' that circumvents the prohibition on the direct patenting of the DNA in our bodies but which, in practice, reaches the same result. (nytimes.com)
  • While the decision will impact patents for certain gene-based diagnostics, the biopharma industry will not likely be significantly altered. (dlapiper.com)
  • Further, many gene patents are old and will expire in one to five years (Myriad's patents on cDNAs expire in 2015). (dlapiper.com)
  • Sumimo is planning to develop a treatment for osteoporosis, and its patent on your so-far-nameless bone-building gene will help assure it gets a return on its investment if its research ever does result in a marketable drug. (ourbeacon.com)
  • The first U.S. patent granting rights to a specific gene or gene sequence hit the books in 1980. (ourbeacon.com)
  • The owners of these patents are typically corporations, academic institutions or charitable research groups, although the U.S. Department of Health is also a major player in the gene-patenting game, having applied for patents covering more than 3,000 pieces of human life. (ourbeacon.com)
  • Looking at the example of the un-named bone-growth gene patented by Sumimo, a more practical problem comes to light. (ourbeacon.com)
  • Sumimo's patent claims that the gene it discovered may lead to an effective treatment for osteoporosis. (ourbeacon.com)
Companies15
  • Under the terms of the settlement, Semicondutor Manufacturing will pay Taiwan Semiconductor $175 million over six years and the two companies will cross license each others patents through December 2010. (marketwatch.com)
  • Under EU law, companies that hold patents for technologies that are essential for industry standards have to make these available to rivals at a fair price. (salon.com)
  • The Commission has increased its scrutiny of suspected abuse of standard-essential patents especially among technology companies in recent months. (salon.com)
  • The game ends when one of the player's 'companies' runs out of money, patents, or appeals. (osnews.com)
  • Both companies have suffered set back after set back when it comes to patents. (osnews.com)
  • But White expects Monsanto and similar companies to seek weed patents. (wweek.com)
  • And that new turn is the announcement today that a patent pool is being formed by some 20 companies to establish royalty rates and manage royalty payments on implementations of EPC Global RFID standards. (consortiuminfo.org)
  • When other companies are awarded patents, they simply join the pool, and the royalty that implementers are charged doesn't go up. (consortiuminfo.org)
  • Innovators and companies from the country filed close to 600,000 patents in this year which is 1.6% less compared to the preceding year. (jkpeterson.net)
  • Chinese companies have long recognized that their patent strategies are critical to their success in U.S. markets. (fenwick.com)
  • Companies worried that because the research results were in the public domain and unprotected by patents, they'd face competition and limited profits if they decided to develop a technology further. (theconversation.com)
  • Microsoft delivers on its promise and files suit against Salesforce.com for infringing on nine of its patents, none of which are tied to the companies' online CRM offerings. (zdnet.com)
  • With the patent boom has come growth in the number of university-related startup companies and in income from patent licensing. (technologyreview.com)
  • Community leaders such as Richard Stallman, Alan Cox, Bruce Perens, and Linus Torvalds and companies such as Red Hat, and MySQL, and community groups such as FSFE, IFSO, all believe that patents cause problems for free software. (wikipedia.org)
  • Some software companies who hold significant patent portfolios have made non-aggression pledges to the free software community. (wikipedia.org)
Ownership1
System6
  • It may be non-news that mega-corp B is throwing legal fees at mega-corp A. For me, the value is that it is being report which helps to draw attention to the rabies riddled dog that is the US patent system. (osnews.com)
  • Redmond filed a patent this week for the system, which would monitor, record and analyze your brain activity while you're using your PC. (itbusinessedge.com)
  • This patented system eliminates the need for multiple-piece components, streamlining the installation process. (thomasnet.com)
  • This U.S. patent further covers the unique method of retrofitting a fluorescent lamp fixture facilitated only by the Litetronics retrofit system and kit. (thomasnet.com)
  • At the core of the '949 Patent are aspects of Sonos's unconventional system architecture - a "controller" and a plurality of "independent playback devices" (e.g., "zone players") communicating over a "local area network" (LAN). (cepro.com)
  • Early patent laws encouraged all citizens to participate in the system. (theconversation.com)
Process6
  • The patent describes a process for identifying the accent of a person and then adjusting the computer generated voice to produce an output with a similar accent. (techspot.com)
  • The '359 Patent does not teach or claim any new hardware, software, or other computer technology for performing this routine process. (techdirt.com)
  • It certainly helped me understand the basics of patenting process. (coursera.org)
  • The Federal Circuit announced en banc that the so-called 'machine-or-transformation' test would henceforth be the sole test to determine whether a claimed process describes patentable subject matter. (fenwick.com)
  • But there's a hitch in the process, and it's not just the strangeness of someone patenting his or her discovery of a naturally occurring part or process of the human body. (ourbeacon.com)
  • Finishing room fire, ash borers and pine beetles, soyboard panels, and amazing cedar wood chip sculptures using a patented process were among the most viewed reports this week at Woodworking Network. (woodworkingnetwork.com)
19871
  • The PMPRB is a quasi-judicial body established in 1987 under the Patent Act with the mandate of ensuring that prices charged for patented medicines sold in Canada are not excessive. (mccarthy.ca)
Royalties1
  • I assume all the local Amazons round the world have been paying one-click royalties to the group patent holder in a tax haven somewhere. (teleread.org)
Case11
  • The lawsuit also challenged the patents on First Amendment grounds, but Judge Sweet ruled that because the issues in the case could be decided within patent law, the constitutional question need not be decided. (nytimes.com)
  • Axon said the U.S. District Court for Kansas found that Axon's signal technology did not infringe on Digital Ally's patent, and dismissed the case in its entirety. (marketwatch.com)
  • However, this effort has proven to be both unsustainable expensive (particularly in the case of Motorola) and a legal dead end, due to the fact that most of the patents it acquired are already committed to FRAND (Fair, Reasonable and Non Discriminatory) licensing, which prevents them from being effectively used to win sales bans against Apple's products. (appleinsider.com)
  • The US is clearly a special case - the only country stupid enough to allow complex patent cases to be handled by a random group of idiots (i.e., people like us) instead of proper judges and specialists. (osnews.com)
  • In this billion dollar case which was the largest court win between Samsung and Apple, there was a combination of both design patent violations and utility patent violations. (coursera.org)
  • Rothschild Patent Imaging, LLC offered to let us settle for a high five figure amount, for which they would drop the case and give us a license to carry on developing Shotwell. (techrepublic.com)
  • Two other patent-infringement claims in that case - also involved in the Lenbrook lawsuit - were settled out of court. (cepro.com)
  • However, where a patent contains an explicit promise of a specific result, the case-law has developed a requirement that this so-called 'promised utility' be demonstrated or soundly predicted as of the Canadian filing date of the patent application. (mccarthy.ca)
  • In this case, Astra's '653 patent was invalidated for lack of utility. (mccarthy.ca)
  • The Court stated that the law in this area is "unsettled", but found that the heightened disclosure requirement vis-à-vis sound prediction only applies in the case of a "new use" patent, if it exists at all. (mccarthy.ca)
  • Where that's the case and the facts and their strategic best interests otherwise allow, they may sue the patent owner first, filing suit in a more neutral, or patent un-friendly, district court. (consortiuminfo.org)
Patents | Encyclopedia.com
Patents | Encyclopedia.com (encyclopedia.com)
Time to eliminate patents altogether? Fed paper urges more open innovation | ZDNet
Time to eliminate patents altogether? Fed paper urges more open innovation | ZDNet (zdnet.com)
Who bought those 882 Novell patents? Not just Microsoft | ZDNet
Who bought those 882 Novell patents? Not just Microsoft | ZDNet (zdnet.com)
IBM patents cloud data location management tech | ZDNet
IBM patents cloud data location management tech | ZDNet (zdnet.com)
Biggest patent win ever? Microsoft's billion dollar a year Samsung deal | ZDNet
Biggest patent win ever? Microsoft's billion dollar a year Samsung deal | ZDNet (zdnet.com)
Apricus Bioscience Inc. - The New York Times
Apricus Bioscience Inc. - The New York Times (nytimes.com)
India scouts for patents to hasten tech development | ZDNet
India scouts for patents to hasten tech development | ZDNet (zdnet.com)
Boeing Scientist Patents Force Field Tech That Blocks Shock Waves
Boeing Scientist Patents Force Field Tech That Blocks Shock Waves (eweek.com)
Mike Lee and Brian LeRoux on Mobile Development, Patents, Cross Platform UIs
Mike Lee and Brian LeRoux on Mobile Development, Patents, Cross Platform UIs (infoq.com)
Patent Infringement | Benzinga
Patent Infringement | Benzinga (benzinga.com)
'292 patent |...
'292 patent |... (benzinga.com)
Article: Debt, Toll Roads and Patents | OpEdNews
Article: Debt, Toll Roads and Patents | OpEdNews (opednews.com)
Answers - The Most Trusted Place for Answering Life's Questions
Answers - The Most Trusted Place for Answering Life's Questions (answers.com)
VI Systems granted 3 US optics patents | light speed | Jul 2013 | Photonics Spectra
VI Systems granted 3 US optics patents | light speed | Jul 2013 | Photonics Spectra (photonics.com)
LED makers wage patent war | Aug 2011 | Photonics Spectra
LED makers wage patent war | Aug 2011 | Photonics Spectra (photonics.com)
Q7 Restoration Project - 'The Greek Goddess' - Questar Forum - Cloudy Nights
Q7 Restoration Project - 'The Greek Goddess' - Questar Forum - Cloudy Nights (cloudynights.com)
Another patent lawsuit: This time, Microsoft sues Salesforce | ZDNet
Another patent lawsuit: This time, Microsoft sues Salesforce | ZDNet (zdnet.com)
Design Patent | JD Supra
Design Patent | JD Supra (jdsupra.com)
Central nervous system: Latest News & Videos, Photos about Central nervous system | The Economic Times
Central nervous system: Latest News & Videos, Photos about Central nervous system | The Economic Times (economictimes.indiatimes.com)
Actavis | Benzinga
Actavis | Benzinga (benzinga.com)
Real World Technologies - Forums - Thread: Expiry of x86-64 patents
Real World Technologies - Forums - Thread: Expiry of x86-64 patents (realworldtech.com)
Real World Technologies - Forums - Thread: Expiry of x86-64 patents
Real World Technologies - Forums - Thread: Expiry of x86-64 patents (realworldtech.com)